sample_name	total_templates	total_reads	productive_templates	total_productive_reads	fraction_productive	total_rearrangements	productive_rearrangements	productive_clonality	max_productive_frequency	locus	sample_tags
HIP15860	248831	7203670	196351	5684389	0.7891	89702	72532	0.2714	6.617562	TCRB	Cohort 01, HLA-A*01, HLA-A*68, HLA-B*14, HLA-B*57, Human, Inferred HLA-A*01, Inferred HLA-A*33, Inferred HLA-B*14, Inferred HLA-B*57, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14363	401483	3854559	328191	3150897	0.8174	284760	229728	0.0495	0.750294	TCRB	Cohort 01, HLA-A*02, HLA-A*11, HLA-B*35, Human, Inferred HLA-A*02, Inferred HLA-B*35, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14178	290259	3873058	240292	3206331	0.8279	189096	155624	0.0701	0.441564	TCRB	Cohort 01, HLA-A*01, HLA-A*03, HLA-B*08, HLA-B*40, Human, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*08, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13944	71534	2339825	55933	1829553	0.7819	39180	31931	0.2000	10.251411	TCRB	Cohort 01, HLA-A*02, HLA-A*03, HLA-B*18, HLA-B*44, Human, Inferred HLA-A*03, Inferred HLA-A*29, Inferred HLA-B*18, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13911	514710	7281001	431432	6102965	0.8382	332924	279856	0.1519	2.293279	TCRB	22 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*68, HLA-B*15, HLA-B*38, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*68, Inferred HLA-B*38, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13513	469425	6802815	381726	5531912	0.8132	336010	270511	0.0732	1.590372	TCRB	56 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*24, HLA-B*07, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*35, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13463	513206	2492135	426624	2071695	0.8313	345364	288100	0.0469	0.376841	TCRB	17 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*31, HLA-B*60, HLA-B*70, Human, Inferred CMV -, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0035_MC1	159450	na	130156	na	0.8163	127026	106782	0.0486	1.927687	TCRB	20 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0037_MC1	274638	na	229522	na	0.8357	240827	202448	0.0185	0.318488	TCRB	24 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0008_MC1	197475	na	158973	na	0.8050	173716	140563	0.0131	0.205695	TCRB	24 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0009_MC1	191710	na	153700	na	0.8017	154804	125191	0.0304	0.375407	TCRB	23 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Hispanic or Latino, Human, Inferred CMV +, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0018_MC1	139289	na	114172	na	0.8197	128571	105421	0.0120	0.445819	TCRB	19 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0021_MC1	373929	na	301733	na	0.8069	336305	272416	0.0129	0.343350	TCRB	26 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0028_MC1	132767	na	107598	na	0.8104	117434	95860	0.0167	0.496292	TCRB	20 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0029_MC1	170592	na	135044	na	0.7916	146460	116185	0.0179	0.450964	TCRB	20 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0030_MC1	176074	na	138321	na	0.7856	145084	116067	0.0281	0.925384	TCRB	23 Years, Caucasian, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0031_MC1	247265	na	199184	na	0.8055	220659	178087	0.0118	0.156639	TCRB	25 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0032_MC1	169825	na	140561	na	0.8277	150020	125080	0.0176	0.368523	TCRB	22 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0033_MC1	167841	na	130728	na	0.7789	142416	112824	0.0360	1.955205	TCRB	24 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0067_MC1	383926	na	326492	na	0.8504	184162	153019	0.2005	7.988251	TCRB	28 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0019_MC1	189727	na	153513	na	0.8091	170411	138122	0.0145	0.526991	TCRB	21 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0020_MC1	106918	na	86340	na	0.8075	85672	70416	0.0306	0.788742	TCRB	20 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0022_MC1	164940	na	135231	na	0.8199	133934	110442	0.0271	0.683275	TCRB	21 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0026_MC1	126003	na	101439	na	0.8051	98398	78609	0.0657	2.865762	TCRB	19 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0027_MC1	89538	na	72648	na	0.8114	75727	60891	0.0291	1.098447	TCRB	24 Years, Caucasian, Cohort 02, Cytomegalovirus -, Hispanic or Latino, Human, Inferred CMV -, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0038_MC1	199064	na	158290	na	0.7952	141830	113974	0.0517	0.488344	TCRB	21 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0039_MC1	123274	na	98082	na	0.7956	100066	79614	0.0294	1.019555	TCRB	27 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0041_MC1	159337	na	131898	na	0.8278	108615	90153	0.0698	2.546665	TCRB	27 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0042_MC1	153710	na	122226	na	0.7952	118953	95049	0.0272	0.319081	TCRB	19 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0050_MC1	171123	na	138526	na	0.8095	130021	104208	0.0679	2.914976	TCRB	25 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0051_MC1	166909	na	137727	na	0.8252	97036	79159	0.1050	2.552876	TCRB	31 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0060_MC1	338562	na	286032	na	0.8448	235155	200105	0.0634	1.250559	TCRB	22 Years, Caucasian, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0062_MC1	419702	na	355792	na	0.8477	277108	238729	0.0743	1.444664	TCRB	23 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0072_MC1	376358	na	300433	na	0.7983	300198	242121	0.0252	0.202042	TCRB	26 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0078_MC1	375587	na	310264	na	0.8261	272609	227476	0.0392	0.229160	TCRB	23 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0079_MC1	415722	na	335235	na	0.8064	249698	201686	0.0774	2.410548	TCRB	33 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0090_MC1	426857	na	346271	na	0.8112	278229	224070	0.1068	5.096875	TCRB	22 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0097_MC1	580546	na	471321	na	0.8119	452088	369772	0.0294	0.183102	TCRB	22 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0099_MC1	418956	na	334118	na	0.7975	331765	265038	0.0415	0.970017	TCRB	22 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0107_MC1	482407	na	399076	na	0.8273	324737	270612	0.0531	0.742716	TCRB	22 Years, Black or African American, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0073_MC1	545966	na	451095	na	0.8262	327165	271806	0.1398	2.950376	TCRB	24 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0074_MC1	456238	na	369847	na	0.8106	276730	231387	0.0694	0.824665	TCRB	24 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0071_MC1	666966	na	551562	na	0.8270	388516	321404	0.0573	0.349190	TCRB	32 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0091_MC1	474835	na	378284	na	0.7967	281959	231568	0.0962	3.489177	TCRB	23 Years, Black or African American, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0095_MC1	842775	na	696203	na	0.8261	633642	527465	0.0345	0.356505	TCRB	34 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0096_MC1	764783	na	632231	na	0.8267	406255	329498	0.1537	10.768374	TCRB	25 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0101_MC1	876760	na	745814	na	0.8506	398514	350103	0.1819	3.635357	TCRB	35 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0102_MC1	360533	na	297642	na	0.8256	259985	214424	0.0501	2.564826	TCRB	32 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0017_MC1	146776	na	117365	na	0.7996	130071	104432	0.0167	0.380011	TCRB	21 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0016_MC1	176893	na	143352	na	0.8104	145589	122231	0.0314	2.698253	TCRB	22 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0109_MC1	313355	na	250526	na	0.7995	205787	164444	0.0764	2.937819	TCRB	23 Years, Caucasian, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0068_MC1	419158	na	333420	na	0.7955	281142	227446	0.0811	2.262312	TCRB	28 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0069_MC1	965510	na	793040	na	0.8214	719961	591798	0.0309	0.109452	TCRB	28 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0093_MC1	838790	na	706743	na	0.8426	570733	478240	0.0679	4.338069	TCRB	27 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0117_MC1	638224	na	513475	na	0.8045	331272	272565	0.1364	5.619358	TCRB	34 Years, Caucasian, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0120_MC1	584420	na	474402	na	0.8117	397185	325366	0.0459	0.382587	TCRB	26 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0024_MC1	134534	na	108492	na	0.8064	88654	71730	0.0902	1.359547	TCRB	25 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0025_MC1	151245	na	122201	na	0.8080	130839	109604	0.0201	0.742220	TCRB	22 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0086_MC1	342169	na	273701	na	0.7999	252316	202860	0.0427	0.582022	TCRB	27 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0087_MC1	512596	na	416270	na	0.8121	330050	270566	0.0823	1.318135	TCRB	29 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0088_MC1	464756	na	368993	na	0.7939	312940	251621	0.0659	0.661259	TCRB	25 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0089_MC1	408132	na	329804	na	0.8081	271421	219347	0.0877	2.662187	TCRB	34 Years, Black or African American, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0103_MC1	297367	na	239924	na	0.8068	202802	165586	0.0521	0.922792	TCRB	35 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0046_MC1	164606	na	131205	na	0.7971	128762	102491	0.0277	0.570100	TCRB	27 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0047_MC1	189353	na	154968	na	0.8184	158843	129918	0.0321	1.279619	TCRB	30 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0048_MC1	214042	na	175436	na	0.8196	168700	138590	0.0329	0.398436	TCRB	30 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0049_MC1	314444	na	250438	na	0.7964	251601	200280	0.0254	0.353381	TCRB	27 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0052_MC1	56728	na	44656	na	0.7872	43443	35269	0.0880	3.974830	TCRB	33 Years, Caucasian, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0084_MC1	846549	na	726272	na	0.8579	333601	284016	0.2375	4.641236	TCRB	34 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0083_MC1	586448	na	466294	na	0.7951	424540	338056	0.0566	0.547080	TCRB	35 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0114_MC1	609741	na	502105	na	0.8235	510896	423992	0.0131	0.093008	TCRB	19 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0115_MC1	666528	na	556291	na	0.8346	321457	257970	0.2279	8.028172	TCRB	25 Years, Caucasian, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0094_MC1	746530	na	592217	na	0.7933	522843	416728	0.0521	0.802240	TCRB	29 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0015_MC1	178320	na	141783	na	0.7951	146083	116620	0.0316	0.423182	TCRB	20 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0001_MC1	160828	na	128553	na	0.7993	131030	105015	0.0503	2.967648	TCRB	22 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0058_MC1	303454	na	245552	na	0.8092	228475	186609	0.0395	0.456522	TCRB	26 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0081_MC1	579105	na	488096	na	0.8428	341266	287811	0.0815	1.344817	TCRB	28 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0082_MC1	727699	na	593522	na	0.8156	393171	332119	0.1431	4.710525	TCRB	29 Years, Caucasian, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0080_MC1	708281	na	577358	na	0.8152	534757	435689	0.0313	0.388321	TCRB	31 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0085_MC1	419662	na	342181	na	0.8154	255491	211521	0.0826	1.510896	TCRB	30 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0057_MC1	497525	na	404155	na	0.8123	280109	233159	0.1178	1.835187	TCRB	32 Years, Caucasian, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0023_MC1	171954	na	145418	na	0.8457	130401	108940	0.0847	2.543702	TCRB	22 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0036_MC1	167877	na	136956	na	0.8158	122528	98866	0.0824	4.017349	TCRB	23 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0053_MC1	177181	na	144959	na	0.8181	149598	121845	0.0324	1.807408	TCRB	25 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0076_MC1	694525	na	565423	na	0.8141	350892	287910	0.2011	5.458922	TCRB	27 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0104_MC1	670923	na	556400	na	0.8293	479444	397486	0.0376	0.215852	TCRB	30 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0110_MC1	350386	na	285702	na	0.8154	241511	200210	0.0794	3.859266	TCRB	27 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0040_MC1	224949	na	182628	na	0.8119	189838	154653	0.0275	0.998204	TCRB	32 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0043_MC1	151400	na	123640	na	0.8166	110019	89210	0.0763	5.470721	TCRB	19 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0044_MC1	207330	na	166361	na	0.8024	148962	121011	0.0535	2.182603	TCRB	28 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0045_MC1	154801	na	119965	na	0.7750	120689	95471	0.0378	1.592965	TCRB	34 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0113_MC1	733165	na	604769	na	0.8249	572049	471115	0.0260	0.304744	TCRB	20 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0116_MC1	611470	na	494052	na	0.8080	438842	357423	0.0495	0.627464	TCRB	19 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0118_MC1	848716	na	660975	na	0.7788	397497	315296	0.1585	1.969061	TCRB	28 Years, Caucasian, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0119_MC1	590033	na	487792	na	0.8267	421166	353573	0.0425	1.139010	TCRB	24 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0004_MC1	185015	na	150298	na	0.8124	152898	125877	0.0314	1.301415	TCRB	24 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0005_MC1	189668	na	155916	na	0.8220	173862	143222	0.0093	0.264245	TCRB	24 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0007_MC1	170711	na	141919	na	0.8313	118242	96598	0.1090	4.898569	TCRB	22 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0002_MC1	179817	na	147161	na	0.8184	112895	92186	0.1331	12.701735	TCRB	21 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0003_MC1	279447	na	233486	na	0.8355	233505	195801	0.0221	0.367474	TCRB	25 Years, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Native American or Alaska Native, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0010_MC1	169112	na	137541	na	0.8133	146924	119338	0.0129	0.135232	TCRB	24 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0011_MC1	146420	na	115430	na	0.7883	120233	95815	0.0196	0.330936	TCRB	24 Years, Caucasian, Cohort 02, Cytomegalovirus -, Hispanic or Latino, Human, Inferred CMV -, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0063_MC1	179036	na	140377	na	0.7841	134787	106367	0.0348	0.473724	TCRB	23 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0064_MC1	325674	na	257934	na	0.7920	236472	188414	0.0443	0.533857	TCRB	27 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0066_MC1	256710	na	204529	na	0.7967	153715	125961	0.0692	0.683033	TCRB	35 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0075_MC1	290367	na	237650	na	0.8184	225263	184396	0.0306	0.626972	TCRB	25 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0092_MC1	557166	na	450388	na	0.8084	358836	293403	0.0662	0.397879	TCRB	21 Years, Caucasian, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0077_MC1	442638	na	352482	na	0.7963	327011	261430	0.0488	1.505041	TCRB	23 Years, Caucasian, Cohort 02, Cytomegalovirus +, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0108_MC1	314942	na	254094	na	0.8068	182806	145739	0.1206	5.307091	TCRB	29 Years, Black or African American, Cohort 02, Cytomegalovirus +, Female, Hispanic or Latino, Human, Inferred CMV -, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0111_MC1	446196	na	361085	na	0.8093	299641	257736	0.0431	1.104172	TCRB	28 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0054_MC1	314275	na	252230	na	0.8026	234320	189285	0.0367	0.281886	TCRB	33 Years, Caucasian, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0061_MC1	330875	na	278104	na	0.8405	233459	195278	0.0665	3.384705	TCRB	22 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0098_MC1	325453	na	266104	na	0.8176	256130	210546	0.0246	0.328443	TCRB	20 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0056_MC1	347183	na	292879	na	0.8436	252179	214201	0.0550	1.239078	TCRB	32 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0065_MC1	319527	na	262260	na	0.8208	214103	177873	0.0604	1.034851	TCRB	27 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus +, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0059_MC1	1034860	na	815687	na	0.7882	279420	226728	0.3388	9.465518	TCRB	33 Years, Caucasian, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0055_MC1	587879	na	470781	na	0.8008	344534	274344	0.1158	6.470949	TCRB	32 Years, Caucasian, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0112_MC1	383379	na	306424	na	0.7993	230609	191485	0.0802	1.110226	TCRB	28 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0100_MC1	347134	na	285228	na	0.8217	222512	185486	0.0605	0.746070	TCRB	21 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0105_MC1	493745	na	405013	na	0.8203	363572	298495	0.0380	0.729606	TCRB	32 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0070_MC1	970930	na	794743	na	0.8185	686274	563590	0.0366	0.185217	TCRB	23 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0106_MC1	422966	na	347857	na	0.8224	272559	226521	0.0478	0.262464	TCRB	33 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0006_MC1	200560	na	167665	na	0.8360	165919	140154	0.0219	0.180121	TCRB	23 Years, Caucasian, Cohort 02, Cytomegalovirus -, Human, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0012_MC1	132240	na	109005	na	0.8243	116569	96125	0.0203	0.849502	TCRB	25 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus -, Hispanic or Latino, Human, Inferred CMV -, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0034_MC1	239972	na	193483	na	0.8063	211939	171442	0.0133	0.205703	TCRB	21 Years, Caucasian, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0014_MC1	184707	na	150760	na	0.8162	151449	124758	0.0259	0.690501	TCRB	19 Years, Asian or Pacific Islander, Cohort 02, Cytomegalovirus -, Female, Human, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
Keck0013_MC1	325835	na	265537	na	0.8149	273514	222345	0.0302	0.614604	TCRB	23 Years, Caucasian, Cohort 02, Cytomegalovirus +, Human, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13567	392958	8663766	313267	6906787	0.7972	260017	207472	0.0863	0.836149	TCRB	50 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00997	486755	7009725	386190	5561499	0.7934	330252	262006	0.0704	0.315275	TCRB	29 Years, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*15, Inferred HLA-B*62, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP12743	384585	9290761	322224	7784256	0.8378	123519	102132	0.3283	4.830468	TCRB	64 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*60, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*60, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13773	354862	1233758	246835	858181	0.6956	188421	155634	0.1000	1.844483	TCRB	22 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*24, HLA-A*30, HLA-B*13, HLA-B*61, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Inferred HLA-B*44, Native American or Alaska Native, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13251	280715	937436	237192	792094	0.8450	164614	139868	0.0693	1.148349	TCRB	40 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-A*23, HLA-B*07, HLA-B*49, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*23, Inferred HLA-B*07, Inferred HLA-B*49, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13168	347525	1589173	282907	1293687	0.8141	208056	170089	0.0753	1.383797	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*66, HLA-B*41, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP09624	216602	1178872	188508	1025973	0.8703	140461	121560	0.0834	1.306077	TCRB	22 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*24, HLA-B*15, HLA-B*18, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-B*07, Inferred HLA-B*18, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP09430	333561	6747067	270153	5464503	0.8099	240732	193872	0.1285	1.509488	TCRB	23 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*26, HLA-B*08, HLA-B*40, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP09041	287653	1007838	238622	836052	0.8295	137887	114465	0.0873	0.730457	TCRB	54 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*02, HLA-B*08, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP07754	659430	30225613	553357	25363681	0.8391	457584	380655	0.0883	0.498717	TCRB	32 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*24, HLA-B*35, HLA-B*40, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-B*35, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP05832	327128	44119195	294922	39775645	0.9015	139764	110510	0.5169	43.733844	TCRB	54 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-B*07, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05815	312998	1402815	251825	1128649	0.8046	179361	144208	0.0824	0.391441	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*02, HLA-B*07, HLA-B*61, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*07, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP03628	285382	1016558	238797	850619	0.8368	201686	171599	0.0510	1.825024	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*11, HLA-B*14, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*11, Inferred HLA-B*14, Inferred HLA-B*51, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP03494	399854	1751084	331203	1450441	0.8283	281910	233004	0.0543	0.380781	TCRB	28 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*24, HLA-B*18, HLA-B*37, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-B*18, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP02780	283072	1030844	226861	826146	0.8014	180323	146185	0.0771	1.376633	TCRB	Cohort 01, Cytomegalovirus -, Female, Human, Inferred CMV -, Inferred CMV -, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01865	355772	1389101	299987	1171294	0.8432	61255	50328	0.4358	15.237933	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*29, HLA-B*13, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*29, Inferred HLA-A*30, Inferred HLA-B*13, Inferred HLA-B*35, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01161	193357	5210426	159484	4297662	0.8248	151582	125093	0.1154	0.513744	TCRB	21 Years, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14236	392453	1934043	300540	1481091	0.7658	129506	104822	0.3730	10.692186	TCRB	56 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*03, HLA-A*24, HLA-B*07, HLA-B*15, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-B*07, Inferred HLA-B*62, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14106	37608	98220	30379	79341	0.8078	12937	10986	0.1169	3.737034	TCRB	37 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*11, HLA-B*35, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*11, Inferred HLA-A*29, Inferred HLA-B*35, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13923	111539	344205	90790	280177	0.8140	28411	24073	0.2633	6.905992	TCRB	50 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*34, HLA-B*15, HLA-B*38, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-B*07, Inferred HLA-B*52, Inferred HLA-B*61, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13654	478664	3247273	394024	2673074	0.8232	322568	262180	0.0742	1.646756	TCRB	21 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-B*44, HLA-B*57, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13296	299544	994332	248208	823925	0.8286	138529	115952	0.2165	10.734958	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*32, HLA-B*44, HLA-B*49, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14096	375918	1659724	324534	1432860	0.8633	154617	129198	0.1882	4.942702	TCRB	42 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*80, HLA-B*15, HLA-B*58, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*32, Inferred HLA-B*62, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10820	450659	1900890	376877	1589679	0.8363	266821	223401	0.0786	0.449210	TCRB	32 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*24, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*35, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP10759	350779	1476978	297099	1250957	0.8470	190251	162983	0.0931	0.801866	TCRB	46 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*32, HLA-B*15, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05763	7193	711058	4451	440043	0.6188	1492	1110	0.2451	9.064796	TCRB	41 Years, Cohort 01, Cytomegalovirus -, HLA-A*24, HLA-A*26, HLA-B*07, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-B*07, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14211	585327	1869497	476850	1523029	0.8147	234923	192863	0.0509	0.650480	TCRB	23 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*33, HLA-B*07, HLA-B*14, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*14, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14092	696862	2847412	583775	2385334	0.8377	248301	207470	0.0779	3.017020	TCRB	27 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-B*15, HLA-B*40, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*60, Native American or Alaska Native, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01947	607829	1760391	485057	1404822	0.7980	253566	204316	0.0502	1.069317	TCRB	Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*27, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*27, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01129	525570	1665110	427880	1355611	0.8141	223759	181775	0.0332	0.214663	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*24, HLA-A*30, HLA-B*13, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*30, Inferred HLA-B*51, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13938	308540	1309222	266430	1130540	0.8635	133566	117693	0.1390	1.773047	TCRB	48 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*29, HLA-B*45, HLA-B*50, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-A*29, Inferred HLA-B*07, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13810	184870	688725	151109	562951	0.8174	71149	60194	0.1719	2.033925	TCRB	39 Years, Caucasian, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05665	198560	628192	163920	518602	0.8255	126848	106076	0.0665	2.213836	TCRB	33 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-B*07, Inferred HLA-B*57, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03695	297041	1161471	236860	926157	0.7974	160458	135020	0.1444	6.057504	TCRB	29 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*23, HLA-B*41, HLA-B*58, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13667	na	2160194	na	1837670	0.8507	185452	158261	0.1965	5.940240	TCRB	54 Years, Cohort 01, Cytomegalovirus +, HLA-A*24, HLA-A*31, HLA-B*27, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Inferred HLA-B*27, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13284	na	1916219	na	1651121	0.8617	133383	113641	0.1874	3.357900	TCRB	11 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*68, HLA-B*08, HLA-B*55, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*68, Inferred HLA-B*07, Inferred HLA-B*55, Inferred HLA-B*60, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13276	na	1961051	na	1756873	0.8959	220378	196436	0.0296	0.138883	TCRB	53 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*07, HLA-B*08, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10815	na	765288	na	640332	0.8367	94664	80045	0.1432	6.250195	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*11, HLA-B*14, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*11, Inferred HLA-B*14, Inferred HLA-B*35, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP17370	na	572576	na	458635	0.8010	70543	57335	0.0729	2.007261	TCRB	44 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*24, HLA-A*26, HLA-B*07, HLA-B*61, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-A*26, Inferred HLA-B*07, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14361	na	1088142	na	875975	0.8050	156693	125482	0.0760	1.033134	TCRB	Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-B*15, HLA-B*39, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*62, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14241	na	998844	na	851519	0.8525	163056	138312	0.0223	0.171928	TCRB	15 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*24, HLA-B*44, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-B*44, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14066	na	1424734	na	1163129	0.8164	175397	140995	0.1287	3.819611	TCRB	26 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*03, HLA-B*07, HLA-B*08, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13857	na	455811	na	374946	0.8226	90423	74209	0.0448	2.659583	TCRB	38 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-B*14, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*14, Inferred HLA-B*15, Inferred HLA-B*62, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13800	na	423262	na	345191	0.8155	42434	36279	0.2366	3.569908	TCRB	66 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*03, HLA-A*68, HLA-B*07, HLA-B*08, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13695	na	881373	na	744668	0.8449	118884	99007	0.0794	0.997089	TCRB	46 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*29, HLA-B*60, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-B*60, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13625	na	839411	na	687153	0.8186	129090	106186	0.0590	0.602195	TCRB	23 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*11, HLA-A*30, HLA-B*13, HLA-B*35, Hispanic or Latino, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*11, Inferred HLA-A*30, Inferred HLA-B*13, Inferred HLA-B*35, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP13465	na	478809	na	401684	0.8389	68711	57648	0.0543	1.119288	TCRB	40 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-B*44, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*15, Inferred HLA-B*44, Inferred HLA-B*62, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13230	na	433697	na	350278	0.8077	71609	57716	0.0715	1.042315	TCRB	46 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*44, Inferred HLA-B*61, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13206	na	496070	na	414233	0.8350	108578	90265	0.0276	0.562003	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*30, HLA-B*07, HLA-B*13, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-A*30, Inferred HLA-B*07, Inferred HLA-B*08, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP11845	na	744650	na	617066	0.8287	121598	101189	0.0353	0.372407	TCRB	29 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-B*08, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*08, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP09681	na	912714	na	759635	0.8323	113824	93818	0.1493	3.227998	TCRB	32 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*11, HLA-B*18, HLA-B*35, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*11, Inferred HLA-B*18, Inferred HLA-B*35, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP05948	na	835004	na	705633	0.8451	140519	118076	0.0362	0.312344	TCRB	35 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-B*41, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*26, Inferred HLA-B*38, Inferred HLA-B*60, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05934	na	431744	na	359796	0.8334	89179	74495	0.0235	0.490556	TCRB	33 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*24, HLA-A*32, HLA-B*08, HLA-B*39, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-A*32, Inferred HLA-B*07, Inferred HLA-B*08, Inferred HLA-B*39, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP04464	na	1518466	na	1161294	0.7648	186174	154576	0.0729	3.219512	TCRB	17 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*26, HLA-A*28, HLA-B*38, HLA-B*61, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*26, Inferred HLA-A*68, Inferred HLA-B*38, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP04455	na	1058764	na	866838	0.8187	122475	99609	0.1493	6.624191	TCRB	55 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*24, HLA-B*35, HLA-B*38, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Inferred HLA-B*38, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03685	na	604909	na	503168	0.8318	99027	82037	0.0297	0.286783	TCRB	42 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*24, HLA-B*08, HLA-B*39, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*08, Inferred HLA-B*39, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01867	na	1801688	na	1571394	0.8722	284076	247056	0.0201	0.172967	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*29, HLA-B*51, HLA-B*55, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*07, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01359	na	1075319	na	917788	0.8535	168951	143620	0.0283	0.236220	TCRB	37 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-B*18, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01501	na	428986	na	356202	0.8303	49874	42435	0.1737	8.553854	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*32, HLA-B*08, HLA-B*60, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*32, Inferred HLA-B*08, Inferred HLA-B*40, Inferred HLA-B*60, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP00951	na	967503	na	809032	0.8362	147660	124122	0.0527	0.693050	TCRB	Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*24, HLA-B*18, HLA-B*39, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-B*18, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP00779	na	1695684	na	1389463	0.8194	164437	136444	0.1034	0.892719	TCRB	30 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-B*08, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00710	na	819265	na	699506	0.8538	91223	76461	0.0779	2.991826	TCRB	32 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*27, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*27, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14024	151407	420387	130291	361759	0.8605	60835	50857	0.1880	6.944126	TCRB	58 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*11, HLA-B*08, HLA-B*27, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*11, Inferred HLA-A*24, Inferred HLA-B*08, Inferred HLA-B*27, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10545	176933	552212	146517	457286	0.8281	90538	75186	0.0741	1.073945	TCRB	33 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*31, HLA-B*35, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*35, Inferred HLA-B*62, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14110	33131	69620	27682	58170	0.8355	17673	15008	0.0499	1.946020	TCRB	42 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*08, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14080	145463	563504	127067	492243	0.8735	98903	86539	0.0483	0.798386	TCRB	28 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-B*07, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13812	220973	989550	183499	821739	0.8304	80754	68736	0.1285	3.588731	TCRB	62 Years, Caucasian, Cohort 01, Cytomegalovirus -, Human, Inferred CMV +, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13753	12902	26648	11147	23024	0.8640	7613	6619	0.1009	7.609451	TCRB	40 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, Human, Inferred CMV +, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10817	257098	982461	211211	807111	0.8215	125386	105222	0.1587	4.823004	TCRB	26 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*03, HLA-B*60, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*15, Inferred HLA-B*35, Inferred HLA-B*60, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13193	105673	502872	89651	426628	0.8484	66184	56637	0.0929	3.489457	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*29, HLA-B*14, HLA-B*45, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*29, Inferred HLA-B*14, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP05311	350983	8479355	249036	6016448	0.7095	131246	108398	0.3616	12.731814	TCRB	48 Years, Black or African American, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*74, HLA-B*53, HLA-B*70, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*07, Inferred HLA-B*08, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP04958	57170	122951	47816	102835	0.8364	32612	27800	0.0627	1.062868	TCRB	25 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-B*51, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*40, Inferred HLA-B*44, Inferred HLA-B*51, Inferred HLA-B*60, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03184	86308	242725	72069	202683	0.8350	48163	41203	0.0594	1.268483	TCRB	59 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*02, HLA-B*44, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-B*44, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13227	164982	4684014	132464	3760802	0.8029	135388	107915	0.1023	3.371568	TCRB	31 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*33, HLA-B*14, HLA-B*45, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-A*33, Inferred HLA-B*08, Inferred HLA-B*14, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00728	170307	2313467	138324	1879018	0.8122	116888	93132	0.0915	1.968475	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-B*27, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*27, Inferred HLA-B*51, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP05437	563709	3568176	462003	2924397	0.8196	328391	272989	0.0962	0.975552	TCRB	28 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*11, HLA-A*26, HLA-B*35, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*11, Inferred HLA-B*35, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14018	386044	2787842	324963	2346742	0.8418	289542	242947	0.0576	0.915951	TCRB	55 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*24, HLA-B*15, HLA-B*40, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05398	342333	2147738	293053	1838566	0.8560	260043	223715	0.0423	0.228874	TCRB	18 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-B*07, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10639	335884	2492310	280023	2077814	0.8337	256585	213213	0.0651	0.635668	TCRB	51 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*18, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*18, Inferred HLA-B*35, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00594	356131	2918797	289407	2371942	0.8126	198830	161024	0.1787	2.311060	TCRB	21 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*32, HLA-B*07, HLA-B*61, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03591	168282	1125325	134497	899405	0.7992	96490	77619	0.1119	1.138864	TCRB	36 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*24, HLA-B*08, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*07, Inferred HLA-B*08, Inferred HLA-B*35, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10597	242273	1286721	199793	1061110	0.8247	175567	146910	0.0636	0.505320	TCRB	27 Years, Caucasian, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP02126	464311	3041260	392382	2570126	0.8451	351663	297035	0.0565	1.768357	TCRB	13 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*24, HLA-B*15, HLA-B*55, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*15, Inferred HLA-B*62, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP02663	279702	2400946	226707	1946048	0.8105	177552	144222	0.0952	1.522778	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*24, HLA-A*29, HLA-B*07, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-A*29, Inferred HLA-B*07, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01253	369967	1715357	294724	1366495	0.7966	205070	163196	0.0790	1.287015	TCRB	47 Years, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP02790	206009	1400511	170252	1157427	0.8264	130950	109179	0.0694	0.870292	TCRB	11 Years, Cohort 01, Cytomegalovirus +, Female, Hispanic or Latino, Human, Inferred CMV -, Inferred CMV -, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP12099	488308	6431611	418162	5507703	0.8563	252596	205679	0.2436	5.667263	TCRB	18 Years, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*68, HLA-B*44, HLA-B*60, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*68, Inferred HLA-B*44, Inferred HLA-B*60, Male, Native American or Alaska Native, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP04471	322689	3359006	272377	2835297	0.8441	230248	193733	0.0637	0.423271	TCRB	27 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*30, HLA-B*13, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-B*13, Inferred HLA-B*35, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP10821	402057	3461429	338669	2915703	0.8423	258554	217720	0.0693	0.504304	TCRB	54 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*26, HLA-B*55, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP11717	226715	2465525	192812	2096830	0.8505	152504	124436	0.1730	13.755097	TCRB	71 Years, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-B*48, HLA-B*54, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13209	369180	2926153	297151	2355252	0.8049	193482	155819	0.1221	1.664153	TCRB	39 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*03, HLA-B*07, HLA-B*08, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*07, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03592	552879	4503196	452654	3686867	0.8187	383702	310108	0.0700	0.822162	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*32, HLA-B*07, HLA-B*39, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*32, Inferred HLA-B*07, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10694	114168	807743	95182	673421	0.8337	74993	63011	0.1058	3.675412	TCRB	42 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*24, HLA-A*26, HLA-B*08, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-A*26, Inferred HLA-B*08, Inferred HLA-B*57, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05460	243625	2286097	204890	1922622	0.8410	112191	90344	0.2315	11.814491	TCRB	50 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*03, HLA-B*49, HLA-B*57, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*13, Inferred HLA-B*35, Inferred HLA-B*44, Inferred HLA-B*49, Inferred HLA-B*57, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01870	331993	4508941	274181	3723778	0.8259	198515	163152	0.1264	3.484284	TCRB	46 Years, Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-A*24, HLA-B*07, HLA-B*37, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-B*07, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP10787	268403	2496369	228382	2124142	0.8509	173545	145713	0.1593	10.021364	TCRB	41 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*31, HLA-B*40, HLA-B*50, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP02877	151920	1052869	130553	904789	0.8594	77033	65624	0.1347	3.553757	TCRB	42 Years, Cohort 01, Cytomegalovirus -, HLA-A*26, HLA-A*33, HLA-B*14, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*26, Inferred HLA-A*33, Inferred HLA-B*14, Inferred HLA-B*35, Inferred HLA-B*38, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP11613	424276	3473932	338580	2772268	0.7980	292483	235657	0.1127	5.830136	TCRB	61 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, Female, HLA-A*24, HLA-B*38, HLA-B*40, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14004	408175	2069623	335757	1702436	0.8226	258616	212952	0.1006	2.411016	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*25, HLA-A*68, HLA-B*08, HLA-B*40, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*68, Inferred HLA-B*08, Inferred HLA-B*60, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01218	289568	2191365	236415	1789123	0.8164	213153	172213	0.0587	2.178218	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*24, HLA-A*29, HLA-B*07, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-A*29, Inferred HLA-B*15, Inferred HLA-B*44, Inferred HLA-B*62, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14014	457219	2200598	366001	1761569	0.8005	283108	228521	0.0845	0.516812	TCRB	48 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*29, HLA-B*40, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*29, Inferred HLA-B*44, Inferred HLA-B*60, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03495	413358	2210743	351151	1878048	0.8495	271746	230352	0.0539	0.419425	TCRB	62 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*62, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10726	324143	1405181	275881	1195965	0.8511	221329	189407	0.0637	2.075730	TCRB	25 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*03, HLA-B*44, HLA-B*52, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*44, Inferred HLA-B*52, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00898	498992	2669208	399956	2139447	0.8015	332224	265181	0.1006	2.282646	TCRB	39 Years, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*30, HLA-B*18, HLA-B*39, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-B*18, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP05561	334016	1399506	270999	1135469	0.8113	194696	157656	0.0698	0.638591	TCRB	50 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*25, HLA-B*08, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10746	226334	1122926	193907	962045	0.8567	157501	136220	0.0522	1.101716	TCRB	14 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*23, HLA-A*25, HLA-B*07, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*23, Inferred HLA-B*07, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP11774	295622	1700653	257330	1480367	0.8705	140534	118794	0.1706	3.720767	TCRB	66 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, Female, HLA-A*26, HLA-A*33, HLA-B*35, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*26, Inferred HLA-B*35, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05817	356421	1566081	302695	1330015	0.8493	260593	221091	0.0469	0.454130	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*24, HLA-B*38, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*38, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP04480	367792	2462934	299204	2003637	0.8135	231049	188687	0.0603	1.090816	TCRB	33 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*27, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*27, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP12091	241693	1625869	196181	1319711	0.8117	156171	126607	0.0958	1.133960	TCRB	47 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*14, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*14, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13220	212621	1578791	172593	1281573	0.8117	133102	107819	0.0908	1.277883	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*26, HLA-A*30, HLA-B*13, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*26, Inferred HLA-A*30, Inferred HLA-B*13, Inferred HLA-B*35, Inferred HLA-B*44, Inferred HLA-B*57, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14020	317338	1339410	262918	1109718	0.8285	217290	181274	0.0427	0.126969	TCRB	12 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*27, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*27, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00169	164698	1338914	138676	1127369	0.8420	115919	96869	0.0690	2.641903	TCRB	41 Years, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*27, HLA-B*37, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*27, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13774	265658	2933224	216738	2393085	0.8159	157770	129945	0.1277	2.234689	TCRB	43 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, Human, Inferred CMV -, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13361	394539	1980298	314987	1581006	0.7984	209927	173652	0.1590	2.144647	TCRB	20 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*23, HLA-A*68, HLA-B*48, HLA-B*49, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*68, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP14059	459947	5091973	386021	4273556	0.8393	337257	280187	0.0525	0.576288	TCRB	50 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*24, HLA-B*08, HLA-B*27, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*08, Inferred HLA-B*27, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13809	317007	1492148	264992	1247318	0.8359	114346	92354	0.3626	16.771504	TCRB	49 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*29, HLA-B*44, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-A*29, Inferred HLA-B*37, Inferred HLA-B*44, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14129	501829	2767122	402535	2219610	0.8021	360025	290230	0.0610	0.467334	TCRB	39 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*25, HLA-B*08, HLA-B*18, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*08, Inferred HLA-B*18, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08399	425910	3366337	349162	2759732	0.8198	293069	239248	0.0813	3.295537	TCRB	47 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-A*24, HLA-B*07, HLA-B*49, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*49, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14103	445394	2490889	375656	2100877	0.8434	269862	224417	0.1643	5.080117	TCRB	43 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*03, HLA-B*07, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*29, Inferred HLA-B*07, Inferred HLA-B*35, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13782	216184	1831630	175075	1483332	0.8098	91372	73642	0.2306	5.199173	TCRB	62 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*24, HLA-B*38, HLA-B*61, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14045	419416	2075548	347399	1719165	0.8283	225879	185934	0.1228	2.951317	TCRB	74 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*68, HLA-B*35, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP09119	316479	1880901	265746	1579390	0.8397	189515	159075	0.0733	1.365084	TCRB	Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*03, HLA-B*14, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*14, Inferred HLA-B*51, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13360	405196	1972307	348569	1696677	0.8602	222899	187929	0.1574	2.972457	TCRB	44 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-B*44, HLA-B*49, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13703	145456	1040971	117027	837521	0.8046	101931	83440	0.0538	0.632701	TCRB	49 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*11, HLA-A*29, HLA-B*07, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*11, Inferred HLA-A*29, Inferred HLA-B*07, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14051	480456	3428774	385854	2753652	0.8031	239351	195983	0.1485	1.976248	TCRB	48 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*11, HLA-B*07, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*11, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13757	405594	3953634	333033	3246332	0.8211	329807	271132	0.0383	1.019397	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*24, HLA-B*07, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*07, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14053	577707	4537385	469767	3689616	0.8132	401403	327667	0.0694	0.697850	TCRB	36 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*39, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08725	378568	3095903	296795	2427173	0.7840	209471	168793	0.1545	2.291637	TCRB	26 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*11, HLA-B*07, HLA-B*08, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-A*11, Inferred HLA-B*07, Inferred HLA-B*08, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14072	203472	2930098	164493	2368787	0.8084	140804	113137	0.0749	0.659029	TCRB	25 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*25, HLA-B*18, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*18, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14071	177433	1705714	147987	1422647	0.8340	107542	87513	0.1031	1.043688	TCRB	45 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*68, HLA-B*07, HLA-B*13, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*68, Inferred HLA-B*07, Inferred HLA-B*13, Inferred HLA-B*57, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14034	432511	2691706	353154	2197837	0.8165	322748	261650	0.0468	0.658375	TCRB	52 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*68, HLA-B*08, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*68, Inferred HLA-B*08, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13794	310288	1973337	262416	1668889	0.8457	218890	186871	0.0479	0.343342	TCRB	36 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*32, HLA-B*57, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*07, Inferred HLA-B*35, Inferred HLA-B*57, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14114	208143	1213834	161757	943328	0.7771	110792	89313	0.1331	2.088775	TCRB	57 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*02, HLA-B*07, HLA-B*15, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*62, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13746	327703	1590454	261987	1271513	0.7995	145053	117862	0.1467	1.896009	TCRB	35 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*24, HLA-B*07, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-B*35, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13319	224914	1023922	182974	832991	0.8135	126631	104415	0.0667	0.805891	TCRB	37 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*14, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*14, Inferred HLA-B*57, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08223	398914	3265743	319356	2614440	0.8006	216949	173082	0.1017	0.710401	TCRB	Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*25, HLA-B*14, HLA-B*18, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*25, Inferred HLA-B*07, Inferred HLA-B*14, Inferred HLA-B*18, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13766	80869	1601547	67093	1328742	0.8297	64230	52701	0.0592	0.720531	TCRB	17 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*24, HLA-B*53, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*15, Inferred HLA-B*35, Inferred HLA-B*62, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13256	310034	2931149	254427	2405431	0.8206	219036	180683	0.0689	1.950337	TCRB	65 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-B*08, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*08, Inferred HLA-B*57, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13736	239984	1846170	212240	1632745	0.8844	169847	150013	0.0661	0.944361	TCRB	32 Years, Caucasian, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14028	219409	1466967	189096	1264296	0.8618	139365	118305	0.1081	2.246626	TCRB	55 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*24, HLA-A*25, HLA-B*08, HLA-B*18, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-B*18, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13661	317927	1460973	269029	1236272	0.8462	205900	176084	0.0665	0.365049	TCRB	43 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*02, HLA-B*13, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*13, Inferred HLA-B*15, Inferred HLA-B*62, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14036	325388	1661479	271868	1388201	0.8355	252635	210341	0.0388	0.455554	TCRB	46 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*03, HLA-B*15, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14060	379305	1815560	307680	1472726	0.8112	161435	132221	0.2333	7.396352	TCRB	48 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*24, HLA-B*35, HLA-B*57, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*35, Inferred HLA-B*57, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13777	340921	4663806	288888	3951998	0.8474	243809	205945	0.0827	0.662804	TCRB	36 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*35, HLA-B*41, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*35, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14130	434160	2094508	347636	1677094	0.8007	271889	219805	0.0738	1.561809	TCRB	35 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*40, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*60, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14030	301689	1367010	249345	1129833	0.8265	220382	189598	0.0982	5.722970	TCRB	42 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*24, HLA-B*07, HLA-B*08, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*07, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14055	326453	2950236	265291	2397501	0.8126	212807	174671	0.0692	1.593743	TCRB	57 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*11, HLA-A*24, HLA-B*40, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*11, Inferred HLA-A*24, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13233	398652	3007794	332467	2508436	0.8340	265991	219815	0.0847	0.900481	TCRB	29 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*08, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14090	157541	1476429	127237	1192435	0.8076	113017	91427	0.0736	0.666703	TCRB	59 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*30, HLA-B*07, HLA-B*44, Hispanic or Latino, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*29, Inferred HLA-B*07, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP09253	505335	4873978	416421	4016406	0.8240	330239	269846	0.0563	0.294617	TCRB	52 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*57, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13764	398615	2535659	328905	2092227	0.8251	333840	273345	0.0299	1.018819	TCRB	05 Years, Caucasian, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13833	234301	2810373	197684	2371170	0.8437	171227	144799	0.1182	2.820591	TCRB	30 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*32, HLA-B*35, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*08, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03812	529161	4846044	428681	3925859	0.8101	337792	272693	0.0936	1.805134	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*29, HLA-B*08, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*29, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP02820	552658	8871559	442451	7102471	0.8006	404802	319549	0.0462	0.830106	TCRB	29 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*26, HLA-B*38, HLA-B*58, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*26, Inferred HLA-B*38, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13860	315811	1913417	257248	1558605	0.8146	215255	176123	0.0544	0.414922	TCRB	35 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-A*68, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*68, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP02090	339755	1985698	274365	1603531	0.8075	267378	216654	0.0333	0.473019	TCRB	14 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*26, HLA-B*35, HLA-B*38, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*26, Inferred HLA-B*38, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14161	534565	3197931	440316	2634108	0.8237	300027	246676	0.0941	0.752968	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*68, HLA-B*14, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*68, Inferred HLA-B*08, Inferred HLA-B*14, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03194	320806	2091342	257009	1675454	0.8011	143400	114195	0.1434	2.567006	TCRB	36 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, Human, Inferred CMV +, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14192	459381	2424345	374375	1975735	0.8150	333378	270536	0.0464	0.282376	TCRB	49 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*31, HLA-B*07, HLA-B*15, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01596	323118	3366925	262215	2732310	0.8115	222306	177413	0.0621	1.093361	TCRB	48 Years, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01499	144231	1878988	123552	1609600	0.8566	109624	93289	0.0500	0.238320	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*24, HLA-A*30, HLA-B*07, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-A*30, Inferred HLA-B*51, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14237	147378	1108339	120638	907249	0.8186	113375	93006	0.0516	0.376302	TCRB	39 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-B*35, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*35, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01856	304850	3433610	244535	2754271	0.8021	159576	129291	0.1457	3.847987	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP02931	273638	2891932	236741	2501993	0.8652	188912	161262	0.0397	0.255756	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*27, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*27, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14143	135109	958529	115249	817639	0.8530	83032	71012	0.1014	3.404926	TCRB	Cohort 01, HLA-A*01, HLA-A*32, HLA-B*08, HLA-B*35, Human, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*08, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01180	332834	6503400	265209	5182049	0.7968	242165	189365	0.0835	0.904604	TCRB	35 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*25, HLA-B*18, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*25, Inferred HLA-B*07, Inferred HLA-B*15, Inferred HLA-B*18, Inferred HLA-B*62, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP02737	653662	7903696	532960	6444242	0.8153	365947	294147	0.1398	3.568488	TCRB	44 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*35, HLA-B*38, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*35, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13972	145017	968292	122488	817866	0.8446	120099	101441	0.0347	0.285377	TCRB	28 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-B*27, HLA-B*39, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*39, Inferred HLA-B*44, Male, Native American or Alaska Native, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00851	564757	8547427	465388	7043519	0.8240	388487	313297	0.0776	1.866638	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*24, HLA-A*26, HLA-B*07, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Inferred HLA-B*07, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13880	443317	3601610	387816	3150711	0.8748	235103	202620	0.1600	3.738965	TCRB	49 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*30, HLA-B*18, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*08, Inferred HLA-B*18, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14184	211144	1607818	173306	1319691	0.8208	155810	127871	0.0732	0.494813	TCRB	53 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*32, HLA-B*15, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*44, Inferred HLA-B*62, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00934	474969	2610209	392415	2156535	0.8262	281766	229845	0.0805	2.316123	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*11, HLA-B*07, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-B*35, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP03677	527055	4502651	436118	3725781	0.8275	385144	315125	0.0575	0.711260	TCRB	07 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*24, HLA-A*33, HLA-B*58, HLA-B*63, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03099	358458	5482868	295822	4524813	0.8253	253878	206546	0.0670	0.683984	TCRB	38 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*24, HLA-B*44, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*44, Inferred HLA-B*62, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13818	352624	2716265	288813	2224735	0.8190	217587	176507	0.1354	2.685938	TCRB	31 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*24, HLA-B*18, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*08, Inferred HLA-B*18, Inferred HLA-B*35, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13962	143052	2588906	107193	1939945	0.7493	68798	56089	0.2224	10.882783	TCRB	42 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*03, HLA-A*23, HLA-B*07, HLA-B*08, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-A*23, Inferred HLA-B*07, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00707	486998	3610152	401948	2979672	0.8254	210822	173227	0.2236	7.318322	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*29, HLA-B*44, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*29, Inferred HLA-B*15, Inferred HLA-B*44, Inferred HLA-B*62, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP02928	591847	5697499	497931	4793411	0.8413	331962	269874	0.1486	1.995260	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*33, HLA-B*14, HLA-B*50, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*33, Inferred HLA-B*14, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13976	316151	3191015	253390	2557556	0.8015	159266	126441	0.1541	1.689621	TCRB	36 Years, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*24, HLA-B*07, HLA-B*14, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*07, Inferred HLA-B*14, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP13978	420757	4141407	343608	3382052	0.8166	274167	224148	0.0870	1.495719	TCRB	28 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-B*08, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13894	195501	1894016	157326	1524185	0.8047	74875	60551	0.1380	2.081112	TCRB	46 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01470	414988	3664365	340406	3005804	0.8203	254507	208932	0.0711	0.638931	TCRB	30 Years, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-B*08, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*08, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13956	365915	2629561	313494	2252855	0.8567	236415	198603	0.1186	7.974637	TCRB	53 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*18, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*18, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00734	219940	4886531	180326	4006409	0.8199	127886	102141	0.1780	6.598578	TCRB	32 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-B*41, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01597	380965	6235691	308363	5047345	0.8094	256406	208919	0.0646	0.551894	TCRB	27 Years, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP02103	473502	4023589	392244	3333104	0.8284	382687	317498	0.0334	0.085116	TCRB	10 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*11, HLA-A*31, HLA-B*07, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*11, Inferred HLA-B*07, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14231	356026	2452863	286696	1975214	0.8053	261637	208954	0.0619	0.641044	TCRB	45 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*24, HLA-B*15, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00110	224859	4059338	179411	3238889	0.7979	130940	104850	0.1007	1.371890	TCRB	55 Years, Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-A*24, HLA-B*07, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-B*07, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13877	347278	2253336	273035	1771609	0.7862	268975	211911	0.0420	0.405281	TCRB	08 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*32, HLA-A*69, HLA-B*35, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00826	433793	4913246	354699	4017411	0.8177	213624	175004	0.1592	2.435150	TCRB	38 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*23, HLA-B*49, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*23, Inferred HLA-B*35, Inferred HLA-B*62, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14183	243366	1758784	203085	1467679	0.8345	77954	65093	0.2761	6.448345	TCRB	57 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*03, HLA-B*07, HLA-B*08, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13919	347456	2165466	279390	1741258	0.8041	171000	139579	0.1669	5.988314	TCRB	46 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*11, HLA-A*29, HLA-B*15, HLA-B*18, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*11, Inferred HLA-B*08, Inferred HLA-B*18, Inferred HLA-B*62, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13966	428059	2737821	366143	2341816	0.8554	259136	221468	0.0664	0.643560	TCRB	48 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*25, HLA-B*44, HLA-B*49, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14160	336727	3520064	281119	2938754	0.8349	196061	164848	0.1006	1.570121	TCRB	Cohort 01, HLA-A*23, HLA-A*24, HLA-B*15, HLA-B*44, Human, Inferred HLA-A*23, Inferred HLA-B*35, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP03814	611344	6874232	498431	5604588	0.8153	433613	351743	0.0654	0.549514	TCRB	Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13822	452039	3576557	382505	3026402	0.8462	284760	240255	0.1190	1.311524	TCRB	48 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*66, HLA-B*08, HLA-B*58, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14140	258406	1380851	210354	1124077	0.8140	202587	165779	0.0564	1.137822	TCRB	34 Years, Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-A*26, HLA-B*18, HLA-B*55, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*11, Inferred HLA-A*26, Inferred HLA-B*18, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP02024	601587	7876368	515399	6747939	0.8567	347237	286828	0.1946	4.857572	TCRB	51 Years, Cohort 01, Cytomegalovirus +, HLA-A*24, HLA-A*68, HLA-B*51, HLA-B*55, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Inferred HLA-A*68, Inferred HLA-B*51, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP00775	475911	6499358	407824	5569529	0.8569	297977	248002	0.1715	4.090759	TCRB	39 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*66, HLA-B*41, HLA-B*57, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00819	256197	5860077	214982	4917372	0.8391	187254	155185	0.0677	0.297720	TCRB	29 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*11, HLA-B*27, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*11, Inferred HLA-B*27, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14223	305719	2477671	256869	2081773	0.8402	147891	120008	0.2355	10.007528	TCRB	44 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*31, HLA-B*35, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*31, Inferred HLA-B*35, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03125	449252	5326721	383776	4550390	0.8543	283492	237761	0.0693	1.720424	TCRB	46 Years, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP03651	425029	6560655	352650	5443434	0.8297	294069	241274	0.0561	1.264000	TCRB	38 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*24, HLA-B*07, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14176	308222	2877731	254858	2379503	0.8269	187435	156457	0.1306	2.760492	TCRB	32 Years, Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-B*07, HLA-B*08, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*08, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13947	306077	1762043	249465	1436141	0.8150	198758	163094	0.0944	1.657289	TCRB	48 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*26, HLA-A*29, HLA-B*38, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*26, Inferred HLA-A*29, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP00813	209730	1696739	171720	1389237	0.8188	119023	97990	0.0928	3.069599	TCRB	32 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14234	306024	3522379	245041	2820459	0.8007	193396	157561	0.1337	2.542494	TCRB	Cohort 01, HLA-A*03, HLA-A*29, HLA-B*07, HLA-B*44, Human, Inferred HLA-A*03, Inferred HLA-A*29, Inferred HLA-B*07, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14206	424593	2519728	353328	2096815	0.8322	308687	254673	0.0693	2.045340	TCRB	41 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*11, HLA-B*07, HLA-B*15, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-B*07, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13928	530938	5428732	429465	4391192	0.8089	305221	246203	0.1100	1.779221	TCRB	60 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*33, HLA-B*35, HLA-B*58, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-B*08, Inferred HLA-B*58, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13902	372291	2631561	309975	2191080	0.8326	232370	191330	0.1044	1.816182	TCRB	56 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*03, HLA-A*26, HLA-B*35, HLA-B*56, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*26, Inferred HLA-B*35, Inferred HLA-B*38, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01820	329540	4375166	273102	3625872	0.8287	254651	207727	0.0502	0.294936	TCRB	27 Years, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*30, HLA-B*13, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*30, Inferred HLA-B*07, Inferred HLA-B*13, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP06191	293335	2465726	240587	2022342	0.8202	226260	185328	0.0407	0.429502	TCRB	30 Years, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*24, HLA-B*35, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-B*35, Inferred HLA-B*57, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP08977	525641	5170339	425385	4184200	0.8093	370704	296814	0.0568	0.696692	TCRB	24 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*18, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*18, Inferred HLA-B*57, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10443	419208	6552186	346551	5416574	0.8267	255962	208243	0.1025	0.806654	TCRB	55 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*29, HLA-B*07, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*29, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP09022	495251	7709230	402761	6269513	0.8132	292185	232858	0.1698	7.133361	TCRB	47 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*03, HLA-B*08, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*08, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08710	316193	2064269	265209	1731426	0.8388	192500	159295	0.0849	1.109721	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*32, HLA-B*14, HLA-B*27, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*32, Inferred HLA-B*07, Inferred HLA-B*14, Inferred HLA-B*27, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP04532	498982	4667595	403404	3773538	0.8085	366931	294741	0.0476	0.345856	TCRB	25 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*24, HLA-B*07, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*07, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08230	334302	1537601	290146	1334511	0.8679	221163	193357	0.0544	0.708574	TCRB	35 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*24, HLA-A*29, HLA-B*44, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-A*29, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP12034	595811	5511811	469158	4340161	0.7874	507650	394537	0.0279	0.048040	TCRB	02 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*24, HLA-B*07, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP04552	466512	6465754	379786	5263751	0.8141	356464	285813	0.0522	0.279174	TCRB	19 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*11, HLA-B*35, HLA-B*58, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*11, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08827	309124	3541812	260910	2989401	0.8440	162367	132070	0.1507	4.182845	TCRB	42 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*31, HLA-A*32, HLA-B*15, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*31, Inferred HLA-A*32, Inferred HLA-B*62, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08346	652137	6100072	503935	4713803	0.7727	399438	334763	0.1551	10.451794	TCRB	45 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*51, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*51, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP11857	476114	3517657	388014	2866753	0.8150	269182	213048	0.1500	5.303003	TCRB	51 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08389	599320	6699126	497131	5556878	0.8295	411496	337545	0.0729	0.538558	TCRB	29 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*35, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*35, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10602	432956	3687447	375578	3198765	0.8675	268860	229634	0.0501	0.334442	TCRB	44 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, Human, Inferred CMV -, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP09235	460833	6619972	398671	5727010	0.8651	269608	229287	0.0932	1.211470	TCRB	51 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-B*35, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*35, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00971	669994	7048276	566757	5962233	0.8459	406098	342119	0.1588	6.039985	TCRB	51 Years, Cohort 01, Cytomegalovirus +, Female, Human, Inferred CMV +, Inferred CMV +, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP08805	583102	6542818	476031	5341412	0.8164	532941	430945	0.0308	0.653535	TCRB	03 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*68, HLA-B*07, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*68, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10564	396370	2245160	346412	1962183	0.8740	269042	232966	0.0527	0.530022	TCRB	45 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*24, HLA-A*26, HLA-B*38, HLA-B*48, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-A*26, Inferred HLA-B*38, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08653	515396	5481989	438962	4669002	0.8517	319860	270812	0.0984	2.752494	TCRB	52 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*02, HLA-B*07, HLA-B*08, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP02848	74632	1659872	59903	1332301	0.8026	52989	41943	0.0735	1.153118	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*03, HLA-B*08, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*08, Inferred HLA-B*40, Inferred HLA-B*60, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01055	98797	1821791	79505	1466058	0.8047	73413	58292	0.0821	0.847238	TCRB	29 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*24, HLA-A*29, HLA-B*39, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-A*29, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01805	508340	5165829	406052	4126363	0.7988	358816	286123	0.0664	1.462717	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-B*13, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*30, Inferred HLA-B*13, Inferred HLA-B*35, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP08521	595280	5238989	488596	4300082	0.8208	387364	325075	0.0905	2.005636	TCRB	39 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*24, HLA-B*07, HLA-B*37, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-B*07, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05524	126052	4121084	102236	3342472	0.8111	89098	71064	0.0618	0.522847	TCRB	36 Years, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*30, HLA-B*08, HLA-B*13, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*30, Inferred HLA-B*08, Inferred HLA-B*13, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP08499	605083	4535809	516577	3872354	0.8537	417067	353435	0.1004	2.922408	TCRB	41 Years, Cohort 01, Cytomegalovirus +, Human, Inferred CMV +, Inferred CMV +, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP09029	508983	6853095	419545	5648883	0.8243	391825	323545	0.0639	0.412896	TCRB	25 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*24, HLA-B*35, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*35, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01022	304028	1954828	248024	1594738	0.8158	247839	200801	0.0296	0.090924	TCRB	51 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*26, HLA-B*07, HLA-B*39, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-B*07, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP11758	515303	6911697	439846	5899606	0.8536	308039	255468	0.1350	3.514167	TCRB	35 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*26, HLA-B*40, HLA-B*54, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*26, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP02873	375257	2719765	324439	2351451	0.8646	250496	211333	0.1376	6.354205	TCRB	Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*23, HLA-B*44, HLA-B*60, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01850	333309	5031702	285302	4306987	0.8560	230115	193385	0.0938	1.687560	TCRB	33 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*30, HLA-B*18, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*18, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP05574	402282	6445604	336957	5398929	0.8376	303146	250863	0.0777	1.192348	TCRB	09 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*23, HLA-B*07, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*07, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00761	331049	4210970	279446	3554577	0.8441	184580	151886	0.1208	1.721330	TCRB	33 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*29, HLA-B*44, HLA-B*58, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*29, Inferred HLA-B*44, Inferred HLA-B*57, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP04611	439381	5942876	373526	5052154	0.8501	318576	268251	0.0824	1.345980	TCRB	30 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*11, HLA-B*37, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*11, Inferred HLA-B*07, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08888	518328	5098045	435119	4279639	0.8395	352263	291167	0.0469	0.196722	TCRB	46 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*11, HLA-B*07, HLA-B*52, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*11, Inferred HLA-B*07, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01219	488960	3671284	413560	3105160	0.8458	242073	198330	0.1828	6.334102	TCRB	44 Years, Cohort 01, Cytomegalovirus +, Female, Human, Inferred CMV +, Inferred CMV +, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01266	437139	2809186	355454	2284255	0.8131	339108	275902	0.0399	0.306840	TCRB	32 Years, Cohort 01, Cytomegalovirus -, HLA-A*11, HLA-B*35, HLA-B*55, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*11, Inferred HLA-B*35, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP08816	417978	3844179	307961	2832344	0.7368	235120	191663	0.1854	12.535800	TCRB	37 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*23, HLA-B*07, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-B*07, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP11518	429695	7495000	348503	6078813	0.8110	308054	247850	0.0887	1.880499	TCRB	42 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*26, HLA-A*31, HLA-B*35, HLA-B*38, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*31, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP11553	382863	7168105	304102	5693518	0.7943	269592	219519	0.0783	0.883408	TCRB	08 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus -, HLA-A*26, HLA-A*34, HLA-B*38, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*26, Inferred HLA-B*38, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01232	289823	2839721	240474	2356194	0.8297	191541	155407	0.1131	3.216458	TCRB	54 Years, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*02, HLA-B*39, HLA-B*57, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-A*32, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP08200	272485	4270186	220729	3459119	0.8101	178943	145768	0.0974	1.980273	TCRB	47 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*44, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*62, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10846	586747	5209528	468800	4162321	0.7990	468149	372939	0.0497	0.421832	TCRB	Cohort 01, HLA-A*26, HLA-A*29, HLA-B*35, HLA-B*51, Human, Inferred HLA-A*26, Inferred HLA-B*35, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP02875	398821	3922168	323025	3176766	0.8099	272019	221085	0.0476	0.206373	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*11, HLA-B*08, HLA-B*55, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*11, Inferred HLA-B*08, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP03233	399244	5393655	323873	4375430	0.8112	287415	230946	0.0501	0.275173	TCRB	39 Years, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*24, HLA-B*57, HLA-B*61, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*57, Male, Native American or Alaska Native, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03618	417887	9605476	335505	7711878	0.8029	220222	177880	0.1456	4.824467	TCRB	62 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-B*35, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*35, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13217	351333	5110090	286785	4171257	0.8163	182703	149835	0.1400	7.719280	TCRB	33 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*30, HLA-B*13, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*30, Inferred HLA-B*13, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03228	459279	5857095	376206	4797682	0.8191	382105	312593	0.0343	0.393669	TCRB	08 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*24, HLA-B*07, HLA-B*18, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*07, Inferred HLA-B*18, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05467	113140	2415410	98975	2113019	0.8748	69518	58525	0.1713	2.353315	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*29, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*29, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13325	635167	7940354	523827	6548473	0.8247	419433	344301	0.0708	0.548540	TCRB	42 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP12900	382110	6251682	313837	5134674	0.8213	261861	214549	0.0875	0.876511	TCRB	28 Years, Black or African American, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*33, HLA-B*07, HLA-B*15, Human, Inferred CMV -, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05838	470153	3207950	387297	2642607	0.8238	328357	270369	0.0545	0.678648	TCRB	36 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03381	349571	5041558	280299	4042511	0.8018	192071	150427	0.1130	1.500256	TCRB	42 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*24, HLA-B*44, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*07, Inferred HLA-B*44, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03378	424582	3023030	349554	2488833	0.8233	248596	201475	0.0953	1.420385	TCRB	60 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*68, HLA-B*08, HLA-B*14, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*08, Inferred HLA-B*14, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13671	381810	3949837	318762	3297612	0.8349	261874	214456	0.1059	1.288326	TCRB	47 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*33, HLA-B*14, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*33, Inferred HLA-B*07, Inferred HLA-B*14, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13198	266652	7208862	213627	5775359	0.8011	137090	111838	0.1472	2.449752	TCRB	49 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*61, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03370	559036	6076259	446819	4856556	0.7993	386072	308030	0.1201	3.762790	TCRB	41 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*02, HLA-B*07, HLA-B*52, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*07, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08972	322913	5295139	265876	4359858	0.8234	200059	162920	0.0863	0.724657	TCRB	51 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*51, HLA-B*56, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13954	458549	7227608	378757	5969934	0.8260	341879	282019	0.0555	0.561145	TCRB	35 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*25, HLA-B*08, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*08, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13265	673825	7803205	545144	6313025	0.8090	445329	356593	0.0746	0.911037	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*44, HLA-B*52, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP03111	352364	16837376	280783	13416977	0.7969	222097	180248	0.1695	1.080363	TCRB	26 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*29, HLA-B*08, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*29, Inferred HLA-B*07, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03502	523959	5054224	432330	4170355	0.8251	379007	309814	0.0871	2.198734	TCRB	42 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*24, HLA-A*30, HLA-B*38, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-A*26, Inferred HLA-B*38, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03236	484254	4541085	395851	3712092	0.8174	385323	313925	0.0363	0.478409	TCRB	23 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*24, HLA-A*31, HLA-B*18, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-B*18, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP04511	311860	1463114	256816	1204875	0.8235	164407	135896	0.1000	0.936031	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*24, HLA-B*44, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP09001	516755	3917323	424028	3214401	0.8206	413815	336828	0.0280	0.156328	TCRB	08 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-B*44, HLA-B*61, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05455	361674	1603954	288680	1280241	0.7982	172754	145929	0.2063	12.496163	TCRB	31 Years, Cohort 01, Cytomegalovirus +, HLA-A*24, HLA-A*33, HLA-B*05, HLA-B*14, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Inferred HLA-A*33, Inferred HLA-B*14, Inferred HLA-B*51, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14048	428714	5360605	354989	4438758	0.8280	282001	233031	0.0551	0.400202	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*03, HLA-B*07, HLA-B*55, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*07, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13427	753122	7066170	632634	5935692	0.8400	567651	471962	0.0637	1.483113	TCRB	42 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*03, HLA-A*26, HLA-B*38, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*26, Inferred HLA-B*38, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13686	374264	5293732	307543	4350008	0.8217	208497	169337	0.1651	2.477674	TCRB	52 Years, Cohort 01, Cytomegalovirus -, HLA-A*11, HLA-A*29, HLA-B*13, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*29, Inferred HLA-B*35, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP03107	172904	1839119	135678	1443162	0.7847	75725	61221	0.1553	1.756352	TCRB	36 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*11, HLA-B*17, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*11, Inferred HLA-B*13, Inferred HLA-B*15, Inferred HLA-B*57, Inferred HLA-B*62, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13142	523568	5133508	439311	4307388	0.8391	400364	327817	0.0681	0.571437	TCRB	46 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*24, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08711	431479	3911559	366965	3326712	0.8505	281479	236103	0.0636	0.916491	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*23, HLA-A*24, HLA-B*07, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*23, Inferred HLA-A*24, Inferred HLA-B*07, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13920	369308	4750249	302228	3887432	0.8184	254114	202716	0.0789	1.621353	TCRB	40 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*11, HLA-B*39, HLA-B*57, Hispanic or Latino, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP03004	480680	6032703	396943	4981782	0.8258	314312	258095	0.0902	1.522447	TCRB	42 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*25, HLA-B*08, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*08, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13926	670960	6830391	565976	5761658	0.8435	470362	389081	0.1254	2.659790	TCRB	60 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*31, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03678	267302	32440623	217838	26437592	0.8150	151016	115805	0.1117	0.675928	TCRB	39 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*24, HLA-B*08, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*08, Inferred HLA-B*35, Inferred HLA-B*62, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP04576	352090	1964954	285760	1594780	0.8116	272875	221259	0.0366	1.033121	TCRB	15 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*30, HLA-B*07, HLA-B*18, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*18, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03720	255341	6536535	219719	5624656	0.8605	183275	157760	0.0712	0.875556	TCRB	38 Years, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*26, HLA-B*07, HLA-B*60, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*07, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP12165	136910	3786118	114885	3177042	0.8391	108060	89781	0.0520	0.797692	TCRB	17 Years, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*24, HLA-B*27, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*27, Inferred HLA-B*35, Male, Native American or Alaska Native, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14074	511087	6305059	411495	5076439	0.8051	393049	313653	0.0500	0.493791	TCRB	57 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*11, HLA-A*29, HLA-B*27, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*11, Inferred HLA-A*29, Inferred HLA-B*27, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP12123	396138	3847646	336044	3263964	0.8483	231011	191764	0.1392	6.500194	TCRB	40 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*31, HLA-B*37, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*27, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP09118	504042	2832861	404503	2273424	0.8025	356571	285496	0.0496	0.743724	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*24, HLA-B*07, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-B*07, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13848	176723	3211885	147882	2687718	0.8368	117641	98076	0.0808	1.195029	TCRB	31 Years, Caucasian, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03197	407375	3410369	335678	2810160	0.8240	229967	190204	0.0828	0.894362	TCRB	28 Years, Caucasian, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP04527	550622	3863730	429438	3013381	0.7799	180670	150660	0.2912	8.854207	TCRB	54 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*15, Inferred HLA-B*62, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13853	581626	6117355	475089	4996842	0.8168	463342	373273	0.0301	0.221360	TCRB	07 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*26, HLA-A*68, HLA-B*27, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*68, Inferred HLA-B*27, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14015	299273	6999832	243039	5684558	0.8121	172736	135491	0.1004	1.622941	TCRB	60 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13941	456403	5353814	380884	4467952	0.8345	302180	249820	0.0609	0.569769	TCRB	41 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13015	555297	5256837	457517	4331189	0.8239	419633	340726	0.0568	0.862535	TCRB	39 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*07, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*07, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13929	478212	4099488	393481	3373136	0.8228	285222	234277	0.1042	1.585824	TCRB	53 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*33, HLA-B*14, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-B*14, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13263	325499	3722616	278125	3180818	0.8545	183804	155363	0.1040	2.255395	TCRB	40 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*31, HLA-B*07, HLA-B*27, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*31, Inferred HLA-B*07, Inferred HLA-B*27, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13176	513259	4036813	436340	3431841	0.8501	351298	297282	0.0641	0.407828	TCRB	36 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*25, HLA-B*08, HLA-B*18, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*25, Inferred HLA-B*07, Inferred HLA-B*08, Inferred HLA-B*18, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13414	313516	3222450	255079	2621815	0.8136	196578	157559	0.0934	1.089970	TCRB	48 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*24, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13370	552350	7105657	421245	5419080	0.7626	306301	234476	0.1145	2.804590	TCRB	65 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*26, HLA-B*07, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*26, Inferred HLA-B*07, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03746	451273	2240027	357896	1776525	0.7931	298096	241253	0.0839	1.811176	TCRB	42 Years, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP03505	272586	3183466	213457	2492921	0.7831	150008	129449	0.1412	9.805445	TCRB	49 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-B*08, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*60, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP03383	210607	2165287	169589	1743574	0.8052	162561	131291	0.0514	1.943651	TCRB	Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*32, HLA-B*44, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*44, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13786	606164	5681883	499439	4681496	0.8239	473359	387616	0.0337	0.091915	TCRB	13 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*03, HLA-B*08, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*35, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13989	317142	5539154	269031	4698872	0.8483	150388	123945	0.1743	2.142536	TCRB	70 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-A*29, HLA-B*40, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*29, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05540	352014	2181641	290281	1799046	0.8246	248160	203002	0.0442	0.378367	TCRB	21 Years, Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-A*24, HLA-B*07, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-B*07, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP03275	502541	3601147	428492	3070525	0.8527	270012	223892	0.1704	8.143917	TCRB	54 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*11, HLA-B*07, HLA-B*55, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*11, Inferred HLA-B*07, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP04475	516144	6833728	403396	5340959	0.7816	359250	282846	0.0983	1.813270	TCRB	55 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*32, HLA-A*33, HLA-B*14, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-B*14, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP09365	498077	4160017	407711	3405273	0.8186	334784	269493	0.0634	0.707080	TCRB	43 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*28, HLA-B*35, HLA-B*53, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*35, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP09150	340975	1445984	281021	1191736	0.8242	216663	176808	0.0799	2.124464	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*29, HLA-B*44, HLA-B*60, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*29, Inferred HLA-B*44, Inferred HLA-B*60, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14148	441261	2517246	360287	2055321	0.8165	239707	192467	0.1294	2.230795	TCRB	21 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*32, HLA-B*13, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*30, Inferred HLA-B*13, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP09344	466009	4336155	402365	3743957	0.8634	316882	272136	0.0637	0.803775	TCRB	35 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*24, HLA-A*31, HLA-B*35, HLA-B*48, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-A*31, Inferred HLA-B*35, Native American or Alaska Native, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP09190	234790	1830226	196602	1532551	0.8374	193137	159463	0.0522	1.824018	TCRB	Cohort 01, Cytomegalovirus +, Female, HLA-A*11, HLA-A*31, HLA-B*07, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*11, Inferred HLA-B*07, Inferred HLA-B*51, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14134	410215	4132902	341410	3439698	0.8323	203202	169367	0.1517	2.660437	TCRB	Cohort 01, HLA-A*02, HLA-A*25, HLA-B*18, HLA-B*39, Human, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*18, Inferred HLA-B*39, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP09284	376756	5179121	305378	4197921	0.8105	249311	199493	0.0709	0.656039	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*03, HLA-B*07, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*51, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14077	390207	6102544	334162	5226055	0.8564	276047	234031	0.0494	1.126892	TCRB	25 Years, Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-A*33, HLA-B*07, HLA-B*50, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*08, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14175	438683	6617567	350621	5289145	0.7993	336436	269638	0.0732	1.257046	TCRB	59 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*68, HLA-B*18, HLA-B*56, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*68, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP09364	308885	1392146	248328	1119219	0.8039	190175	158009	0.0719	3.066156	TCRB	15 Years, Black or African American, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*32, HLA-B*18, HLA-B*53, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-A*32, Inferred HLA-B*08, Inferred HLA-B*18, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14109	567550	5670903	483549	4831579	0.8520	390678	327921	0.0525	0.976886	TCRB	54 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-B*07, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13994	369729	3935185	310281	3302460	0.8392	197973	162639	0.2038	7.739322	TCRB	64 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-B*07, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13489	382236	2492526	318015	2073751	0.8320	241742	200953	0.0948	2.048028	TCRB	44 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*24, HLA-A*25, HLA-B*18, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Inferred HLA-A*25, Inferred HLA-B*07, Inferred HLA-B*18, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP15854	523975	6438504	425721	5231184	0.8125	342172	275688	0.1274	2.585992	TCRB	30 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*23, HLA-B*07, HLA-B*58, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*23, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13122	419227	2074469	352185	1742726	0.8401	264660	220693	0.0774	1.366423	TCRB	41 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP17737	253281	1515663	219746	1314990	0.8676	134875	115390	0.1527	3.033255	TCRB	Cohort 01, HLA-A*03, HLA-A*33, HLA-B*15, Human, Inferred HLA-A*03, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13214	437026	5563602	357206	4547454	0.8174	305087	244485	0.0780	1.807055	TCRB	43 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*29, HLA-B*07, HLA-B*27, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-B*07, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14079	517488	4622168	431408	3853310	0.8337	397967	329128	0.0385	0.562140	TCRB	10 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*26, HLA-B*13, HLA-B*15, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13294	426559	4054504	351332	3339469	0.8236	279929	228647	0.0693	0.429799	TCRB	39 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*68, HLA-B*08, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*68, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14118	505716	36871402	410112	29900987	0.8110	401947	314263	0.0962	1.283433	TCRB	59 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*32, HLA-B*38, HLA-B*57, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10514	463883	3116482	379578	2550102	0.8183	307470	255082	0.0695	0.537273	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*68, HLA-B*35, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*68, Inferred HLA-B*35, Inferred HLA-B*60, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13178	289898	6390187	230708	5085489	0.7958	217409	170379	0.0514	0.404071	TCRB	21 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-B*14, HLA-B*37, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*14, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05377	372665	2916464	311213	2435546	0.8351	213933	177132	0.0849	0.806636	TCRB	39 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*31, HLA-B*08, HLA-B*49, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*31, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP17449	408064	4058065	329140	3273201	0.8066	297058	237436	0.0740	0.401961	TCRB	Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14156	195444	2465171	159176	2007727	0.8144	139148	113077	0.0879	1.830229	TCRB	Cohort 01, HLA-A*02, HLA-A*24, HLA-B*15, HLA-B*44, Human, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*07, Inferred HLA-B*62, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13933	183666	2608305	146850	2085481	0.7995	145693	114904	0.0535	1.839144	TCRB	36 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*26, HLA-A*68, HLA-B*15, HLA-B*38, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*26, Inferred HLA-A*68, Inferred HLA-B*15, Inferred HLA-B*62, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14218	436893	5695164	351904	4587293	0.8055	341828	273074	0.0501	0.263205	TCRB	34 Years, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*25, HLA-B*08, HLA-B*18, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*07, Inferred HLA-B*08, Inferred HLA-B*18, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14170	265626	1694936	218792	1396095	0.8237	104549	86412	0.1971	5.334379	TCRB	Cohort 01, HLA-A*24, HLA-A*32, HLA-B*40, HLA-B*44, Human, Inferred HLA-A*24, Inferred HLA-A*32, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13663	469001	3804597	395828	3211016	0.8440	334029	282557	0.0734	1.768350	TCRB	18 Years, Caucasian, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14221	414474	3980413	358393	3441847	0.8647	256229	217655	0.1045	2.287231	TCRB	67 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*68, HLA-B*35, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*68, Inferred HLA-B*35, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13183	494818	3278971	409325	2712446	0.8272	285537	234449	0.0763	0.935834	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*37, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14138	347596	15970011	286372	13157153	0.8239	257171	209861	0.1062	0.349840	TCRB	Cohort 01, HLA-A*11, HLA-A*32, HLA-B*27, HLA-B*35, Human, Inferred HLA-A*02, Inferred HLA-A*11, Inferred HLA-B*27, Inferred HLA-B*35, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13859	305737	5420796	253790	4499770	0.8301	173173	139429	0.1188	6.267720	TCRB	51 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*26, HLA-B*38, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*26, Inferred HLA-B*38, Inferred HLA-B*57, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13887	372410	2077277	307341	1714328	0.8253	263823	217759	0.0560	0.489871	TCRB	55 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*25, HLA-B*07, HLA-B*39, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*07, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14157	479414	3615815	404090	3047713	0.8429	312613	255690	0.1344	4.238359	TCRB	23 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-B*07, HLA-B*14, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*14, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP12527	340700	2566770	279855	2108380	0.8214	217318	177780	0.0702	0.823523	TCRB	46 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*25, HLA-A*29, HLA-B*38, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*26, Inferred HLA-A*29, Inferred HLA-B*38, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14214	412623	2039014	351344	1736199	0.8515	278533	235237	0.0618	2.371041	TCRB	60 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*24, HLA-B*07, HLA-B*37, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-B*07, Inferred HLA-B*37, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13720	384580	2482733	317088	2047027	0.8245	274544	228176	0.0654	0.741856	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*11, HLA-B*07, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*11, Inferred HLA-B*07, Inferred HLA-B*35, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP12129	291859	1212032	244632	1015911	0.8382	167818	142746	0.0913	2.969059	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*24, HLA-B*35, HLA-B*39, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*35, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP17887	362090	2405765	305049	2026781	0.8425	233512	196456	0.0621	0.532717	TCRB	Cohort 01, HLA-A*02, HLA-A*29, HLA-B*07, HLA-B*44, Human, Inferred HLA-A*02, Inferred HLA-A*29, Inferred HLA-B*07, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13157	458580	6602049	365565	5262950	0.7972	239092	187930	0.1398	1.520782	TCRB	31 Years, Black or African American, Cohort 01, Cytomegalovirus +, HLA-A*68, HLA-B*41, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*68, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13722	240144	1672125	200173	1393811	0.8336	158637	132316	0.0616	0.638609	TCRB	31 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*30, HLA-B*07, HLA-B*41, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14243	453024	3470064	365820	2802104	0.8075	349754	280620	0.0447	0.890545	TCRB	Cohort 01, HLA-A*02, HLA-A*31, HLA-B*07, HLA-B*35, Human, Inferred HLA-A*02, Inferred HLA-B*35, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP17723	409493	5834927	334328	4763895	0.8164	251413	202934	0.1047	0.948782	TCRB	39 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-B*18, HLA-B*39, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*18, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP09775	318318	2500467	272603	2141369	0.8564	174773	146313	0.1660	2.839445	TCRB	37 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, HLA-A*11, HLA-A*34, HLA-B*15, HLA-B*38, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*11, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13789	349857	4834885	291542	4029002	0.8333	224997	182896	0.0842	1.193348	TCRB	63 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*15, Inferred HLA-B*62, Native American or Alaska Native, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13856	491656	5746911	398388	4656722	0.8103	358804	286512	0.0940	4.163895	TCRB	23 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*03, HLA-A*32, HLA-B*07, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*08, Inferred HLA-B*35, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP09366	124076	2478075	100235	2001930	0.8079	78022	61221	0.1574	4.799518	TCRB	22 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*29, HLA-B*07, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*29, Inferred HLA-B*07, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13627	420093	6664409	361121	5728876	0.8596	209249	178540	0.1447	1.600907	TCRB	53 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*24, HLA-A*25, HLA-B*08, HLA-B*18, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-A*25, Inferred HLA-B*07, Inferred HLA-B*08, Inferred HLA-B*18, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP17445	503627	5310219	412680	4351280	0.8194	336615	272583	0.0935	1.521506	TCRB	45 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*11, HLA-A*26, HLA-B*07, HLA-B*38, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*11, Inferred HLA-A*26, Inferred HLA-B*07, Inferred HLA-B*38, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13961	443675	2788645	370702	2329987	0.8355	165100	136807	0.2440	2.871175	TCRB	Cohort 01, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*15, Human, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*62, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14009	291259	6588577	238242	5389285	0.8180	197832	159552	0.0765	1.285310	TCRB	71 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*23, HLA-A*26, HLA-B*18, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-B*18, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14174	534162	3843971	435817	3136261	0.8159	358754	291520	0.0799	0.747355	TCRB	60 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*27, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*27, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14043	434961	4274045	335444	3296164	0.7712	266990	217370	0.1385	6.147388	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10823	338662	2745891	277910	2253316	0.8206	254748	208463	0.0505	1.440011	TCRB	35 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*24, HLA-B*27, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*27, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14037	418422	4763508	337433	3841497	0.8064	221386	178472	0.1290	2.287988	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*24, HLA-A*32, HLA-B*08, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-A*32, Inferred HLA-B*08, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14127	306496	2961740	248750	2403730	0.8116	187208	149611	0.1313	5.834973	TCRB	54 Years, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*03, HLA-B*08, HLA-B*15, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*08, Inferred HLA-B*62, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13964	367283	4480055	297610	3630203	0.8103	274851	221796	0.0598	0.706214	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*11, HLA-B*44, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*11, Inferred HLA-B*44, Inferred HLA-B*51, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP16867	521599	24201820	433014	20091549	0.8302	398849	321470	0.1319	1.276154	TCRB	47 Years, Cohort 01, Cytomegalovirus +, HLA-A*24, HLA-B*07, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Inferred HLA-B*35, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP11513	433128	2241094	337658	1747116	0.7796	331018	260601	0.0460	0.230494	TCRB	09 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, Female, HLA-A*24, HLA-A*34, HLA-B*15, HLA-B*40, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13306	442104	5468644	367393	4544506	0.8310	224639	184068	0.1071	0.798085	TCRB	30 Years, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*68, HLA-B*14, HLA-B*49, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*14, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP17837	368570	2906472	312446	2463890	0.8477	273493	229643	0.0764	1.346813	TCRB	28 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*23, HLA-A*30, HLA-B*44, HLA-B*53, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*23, Inferred HLA-B*35, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13699	484868	5365778	387660	4290033	0.7995	335369	267313	0.0744	1.120504	TCRB	48 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, Human, Inferred CMV +, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13497	292933	4563037	249945	3893420	0.8532	215789	184102	0.0598	0.494784	TCRB	51 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*11, HLA-A*24, HLA-B*39, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*11, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP17793	446467	4072785	369459	3370301	0.8275	278266	226399	0.1423	4.016644	TCRB	Cohort 01, HLA-A*02, HLA-B*07, HLA-B*35, Human, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*35, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13983	457465	2969316	363080	2356683	0.7937	227163	183522	0.1704	3.564544	TCRB	49 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*24, HLA-B*37, HLA-B*39, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03216	297473	2387162	251892	2021390	0.8468	147051	120711	0.1564	5.422061	TCRB	48 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, Human, Inferred CMV +, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14172	431869	2831098	348603	2285255	0.8072	312018	258624	0.0806	2.556257	TCRB	Cohort 01, HLA-A*02, HLA-A*26, HLA-B*27, HLA-B*44, Human, Inferred HLA-A*02, Inferred HLA-A*26, Inferred HLA-B*27, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14153	351110	4503273	290562	3726705	0.8276	265999	218514	0.0435	0.313950	TCRB	60 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*23, HLA-A*68, HLA-B*40, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14187	477711	2538979	407033	2163338	0.8520	236771	196073	0.2406	4.518480	TCRB	43 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13796	583566	5024732	495334	4265022	0.8488	440866	372286	0.0344	0.122930	TCRB	41 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*23, HLA-B*18, HLA-B*49, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*08, Inferred HLA-B*18, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13852	421538	4283093	371330	3772948	0.8809	199199	170475	0.2001	5.245023	TCRB	62 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*66, HLA-B*35, HLA-B*41, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05595	187133	1989093	136834	1454450	0.7312	99537	81856	0.1112	3.694730	TCRB	32 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*23, HLA-A*68, HLA-B*13, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*11, Inferred HLA-A*23, Inferred HLA-A*30, Inferred HLA-A*68, Inferred HLA-B*13, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14196	342508	1831680	277865	1485980	0.8113	179975	144724	0.1787	7.098817	TCRB	63 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-B*07, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13505	68258	1428241	55318	1157493	0.8104	44431	35144	0.1097	2.343340	TCRB	63 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*29, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*29, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13754	409733	3872955	328004	3100423	0.8005	313263	252397	0.0480	0.418620	TCRB	26 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, Human, Inferred CMV -, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14238	577982	5555350	480336	4616814	0.8311	351145	288287	0.0864	0.487327	TCRB	Cohort 01, HLA-A*24, HLA-B*40, HLA-B*44, Human, Inferred HLA-A*24, Inferred HLA-B*44, Inferred HLA-B*60, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP09559	492804	3261380	407945	2699789	0.8278	372591	308064	0.0453	0.418107	TCRB	27 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus -, Female, HLA-A*11, HLA-A*33, HLA-B*35, HLA-B*58, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*11, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13274	563936	5544604	469024	4611432	0.8317	392580	325405	0.0745	0.880854	TCRB	36 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*11, HLA-B*08, HLA-B*14, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*11, Inferred HLA-B*08, Inferred HLA-B*14, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01160	270182	7375399	226156	6173588	0.8371	177009	145336	0.1112	0.766588	TCRB	31 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*51, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*15, Inferred HLA-B*51, Inferred HLA-B*62, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14142	346486	2463225	279522	1987173	0.8067	212971	170088	0.0908	1.216150	TCRB	22 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*24, HLA-A*32, HLA-B*35, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Inferred HLA-B*35, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13814	305787	1619302	256415	1357852	0.8385	156297	128506	0.2213	10.694759	TCRB	41 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*03, HLA-B*07, HLA-B*57, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*13, Inferred HLA-B*57, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14205	403221	2607165	330432	2136528	0.8195	221959	180462	0.1392	6.038161	TCRB	48 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, HLA-A*32, HLA-A*34, HLA-B*40, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01264	442199	6763689	367628	5623091	0.8314	319034	262607	0.0562	0.282656	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*62, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14244	235894	1119549	195815	929339	0.8301	182487	152274	0.0377	0.244905	TCRB	09 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*32, HLA-B*15, HLA-B*42, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*15, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00805	529355	7928296	437636	6554599	0.8267	389184	324293	0.0594	0.280200	TCRB	55 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP00838	519418	8190803	416340	6565359	0.8016	398700	315556	0.0605	0.478176	TCRB	26 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*29, HLA-A*33, HLA-B*14, HLA-B*44, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*29, Inferred HLA-B*14, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP14230	259091	1144165	215871	953304	0.8332	205365	170392	0.0293	0.222699	TCRB	62 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*33, HLA-B*15, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01004	472824	5397969	388953	4440462	0.8226	309878	255406	0.0899	1.029668	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*03, HLA-B*08, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*08, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01384	274933	8470594	214864	6619915	0.7815	142144	114971	0.1917	6.067646	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*29, HLA-A*30, HLA-B*13, HLA-B*45, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*29, Inferred HLA-A*30, Inferred HLA-B*13, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01392	295027	8698115	247756	7304477	0.8398	213027	176729	0.0664	0.264961	TCRB	45 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*29, HLA-B*18, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*29, Inferred HLA-B*18, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01255	506957	9791445	419105	8094661	0.8267	412414	336675	0.0314	0.087119	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*24, HLA-B*35, HLA-B*39, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*24, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP00832	383214	5577950	314448	4577025	0.8206	266994	218728	0.0677	0.618961	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*11, HLA-B*08, HLA-B*27, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*11, Inferred HLA-B*08, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP00771	489770	8864688	399681	7234105	0.8161	400775	325650	0.0511	0.252955	TCRB	35 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*29, HLA-B*07, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01223	471568	8710283	404712	7475399	0.8582	326492	277008	0.1394	4.682466	TCRB	27 Years, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*34, HLA-B*14, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*14, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13900	299846	1981638	254906	1684642	0.8501	161736	135446	0.1298	1.094001	TCRB	51 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, Female, HLA-A*11, HLA-A*31, HLA-B*13, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*31, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00904	305459	8925325	241837	7066331	0.7917	230938	182434	0.0671	0.391603	TCRB	39 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-B*27, HLA-B*61, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*27, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01298	416983	8911787	335678	7174140	0.8050	279329	227254	0.1048	1.044599	TCRB	36 Years, Cohort 01, HLA-A*02, HLA-A*30, HLA-B*13, HLA-B*62, Human, Inferred HLA-A*02, Inferred HLA-A*30, Inferred HLA-B*62, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP00999	518321	8395520	449642	7283100	0.8675	358012	310444	0.0754	1.302083	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*26, HLA-B*14, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*26, Inferred HLA-B*14, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP09122	381678	4259217	310368	3463465	0.8132	268983	215813	0.0574	0.472850	TCRB	Cohort 01, Cytomegalovirus +, Female, HLA-A*11, HLA-A*26, HLA-B*48, HLA-B*75, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*11, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP08236	587261	7996587	478488	6515459	0.8148	436386	355978	0.0428	0.153205	TCRB	23 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*24, HLA-B*07, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*24, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05331	288823	8443810	228582	6682651	0.7914	158862	127509	0.1894	4.967161	TCRB	42 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*24, HLA-A*68, HLA-B*18, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Inferred HLA-A*68, Inferred HLA-B*14, Inferred HLA-B*18, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP00602	427705	9588747	335488	7521347	0.7844	248959	197856	0.1145	0.673071	TCRB	45 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*11, HLA-B*35, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*11, Inferred HLA-B*35, Inferred HLA-B*51, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP08439	549669	9202682	443677	7428141	0.8072	464856	370363	0.0469	0.957979	TCRB	23 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*40, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP08598	488081	9196967	405360	7638257	0.8305	374602	309719	0.0723	1.008097	TCRB	40 Years, Cohort 01, Cytomegalovirus +, HLA-A*03, HLA-A*31, HLA-B*07, HLA-B*08, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-A*31, Inferred HLA-B*07, Inferred HLA-B*08, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP00926	526494	9263881	427828	7527824	0.8126	403329	327300	0.0571	0.324702	TCRB	26 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*35, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*35, Inferred HLA-B*51, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP05405	481429	10014401	394229	8200537	0.8189	317177	253999	0.1627	11.234655	TCRB	40 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*24, HLA-A*30, HLA-B*18, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*08, Inferred HLA-B*18, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00777	426500	6396067	346634	5198359	0.8127	327902	266055	0.0675	0.489597	TCRB	22 Years, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*27, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*27, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP02112	666196	7967804	548421	6559206	0.8232	549611	450806	0.0273	0.123414	TCRB	06 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-B*07, HLA-B*15, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00715	474762	9148409	369421	7118563	0.7781	369173	290599	0.0456	0.858263	TCRB	44 Years, Cohort 01, Cytomegalovirus -, HLA-A*32, HLA-B*14, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*32, Inferred HLA-B*14, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP00924	301250	8820748	244378	7155510	0.8112	220892	178626	0.0858	1.078386	TCRB	37 Years, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*24, HLA-B*08, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*51, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP03732	315011	9663858	249927	7667241	0.7934	214159	170893	0.0874	1.368315	TCRB	47 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*24, HLA-B*44, HLA-B*55, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*44, Inferred HLA-B*55, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP00773	430943	5704905	335872	4446342	0.7794	381128	295321	0.0267	0.097991	TCRB	01 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*24, HLA-B*08, HLA-B*61, Hispanic or Latino, Human, Inferred CMV -, Inferred CMV -, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP00822	215474	7016099	175386	5710786	0.8140	169835	136916	0.0578	1.120774	TCRB	38 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*30, HLA-B*07, HLA-B*18, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*30, Inferred HLA-B*07, Inferred HLA-B*08, Inferred HLA-B*18, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01582	177504	5596901	141058	4447747	0.7947	130852	104594	0.1121	3.899413	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*31, HLA-B*07, HLA-B*27, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*31, Inferred HLA-B*27, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP04510	373051	8920999	291621	6973719	0.7817	140592	111655	0.2614	6.192621	TCRB	49 Years, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*30, HLA-B*14, HLA-B*35, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*14, Inferred HLA-B*35, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP02811	449264	8529444	356304	6764571	0.7931	283037	223420	0.0648	0.311579	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*24, HLA-B*08, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*08, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP09020	337514	9458592	286785	8036952	0.8497	194284	158237	0.1708	4.021686	TCRB	58 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*27, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-B*07, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00985	409287	6611833	340048	5493312	0.8308	311298	259187	0.0550	0.674675	TCRB	53 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*26, HLA-B*14, HLA-B*27, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*27, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP02855	777732	9023380	627911	7285136	0.8074	577179	462189	0.0492	1.871743	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-B*07, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP00640	335467	7297663	272904	5936692	0.8135	253388	205475	0.0564	0.596258	TCRB	37 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*68, HLA-B*27, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*27, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP05535	432932	6863102	357198	5662536	0.8251	296787	244757	0.0820	0.457180	TCRB	25 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-B*44, HLA-B*57, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*44, Inferred HLA-B*57, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08305	434643	10683494	366479	9008034	0.8432	244567	200386	0.1868	5.687123	TCRB	40 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*24, HLA-B*35, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*15, Inferred HLA-B*62, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01091	364294	7073961	292959	5688769	0.8042	245336	191424	0.1203	1.954676	TCRB	56 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, Human, Inferred CMV +, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05533	427552	9210710	364839	7859705	0.8533	309367	262193	0.0694	0.477524	TCRB	22 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-B*14, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*14, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05409	465188	8101395	393464	6852307	0.8458	365555	310720	0.0411	0.246866	TCRB	16 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-B*35, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP02805	397293	8574930	319040	6885976	0.8030	287833	230518	0.0773	0.633810	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*31, HLA-B*35, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*35, Inferred HLA-B*57, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01797	330908	6904896	279711	5836605	0.8453	217016	180845	0.0742	0.976424	TCRB	35 Years, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*30, HLA-B*08, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*30, Inferred HLA-B*08, Inferred HLA-B*13, Inferred HLA-B*57, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP05434	371670	7322871	299685	5904588	0.8063	237094	183339	0.1360	4.049410	TCRB	36 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*03, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-B*35, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08400	430612	9106377	346039	7317871	0.8036	264856	216523	0.0986	1.555890	TCRB	45 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-B*27, HLA-B*57, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*27, Inferred HLA-B*57, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05551	272522	8386908	228034	7017800	0.8368	192489	161070	0.1138	2.331614	TCRB	48 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*03, HLA-B*08, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*08, Inferred HLA-B*35, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03597	465817	7489080	396124	6368619	0.8504	313900	264205	0.0696	0.359246	TCRB	39 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*35, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00769	293596	5245352	250035	4467114	0.8516	238171	203018	0.0422	0.504218	TCRB	23 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*32, HLA-B*08, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*32, Inferred HLA-B*08, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP08507	348657	8134681	279573	6522857	0.8019	300445	239130	0.0321	0.137148	TCRB	46 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*30, HLA-B*18, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*08, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01571	269176	7205218	225595	6038664	0.8381	180087	151474	0.0814	1.394828	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*51, HLA-B*63, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*51, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP02962	438337	8817651	365232	7347071	0.8332	255770	207230	0.2304	9.021595	TCRB	61 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*29, HLA-B*45, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*29, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05578	449592	8445892	372015	6988568	0.8275	308367	256665	0.0701	0.723768	TCRB	29 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*30, HLA-B*14, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-B*14, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP04578	539904	7073236	443952	5816180	0.8223	321120	268723	0.1235	5.962951	TCRB	42 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*03, HLA-A*24, HLA-B*07, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-B*07, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05590	132531	6659932	105104	5281715	0.7931	80667	64832	0.1671	4.978932	TCRB	49 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*23, HLA-B*07, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*35, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08337	266091	8043303	218272	6597871	0.8203	162946	133179	0.1121	3.414086	TCRB	50 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*68, HLA-B*49, HLA-B*63, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-A*68, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP01140	381093	8324897	317500	6935723	0.8331	301293	248772	0.0409	0.617441	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*35, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*35, Inferred HLA-B*51, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP00825	497074	6095742	401154	4919456	0.8070	401218	324192	0.0568	1.284370	TCRB	10 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*11, HLA-A*25, HLA-B*27, HLA-B*58, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-B*27, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08792	476519	7440106	385234	6014837	0.8084	313208	259695	0.1357	3.958395	TCRB	51 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*29, HLA-A*31, HLA-B*07, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*29, Inferred HLA-B*07, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP02997	271285	9079767	197927	6624518	0.7296	163156	126885	0.1571	3.331790	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*29, HLA-B*07, HLA-B*57, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*29, Inferred HLA-B*57, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP04509	468061	7151039	365965	5591229	0.7819	187807	151152	0.2814	4.914465	TCRB	26 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*14, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*14, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05444	465969	5129973	391477	4309876	0.8401	392899	331691	0.0337	0.064689	TCRB	38 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*24, HLA-B*08, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*08, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP05841	498869	5195158	413474	4305866	0.8288	307028	252851	0.1517	2.381821	TCRB	33 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*03, HLA-B*27, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP00869	534234	8755600	426332	6987187	0.7980	367425	296375	0.0766	0.660395	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-B*18, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*08, Inferred HLA-B*18, Inferred HLA-B*35, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP02742	167539	6529414	140005	5456353	0.8357	124436	101196	0.0872	2.952302	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*11, HLA-B*18, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*18, Inferred HLA-B*35, Inferred HLA-B*62, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP02271	349056	8029928	299649	6893337	0.8585	262519	220772	0.0877	1.973195	TCRB	54 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, Human, Inferred CMV +, Inferred CMV +, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP11649	433293	7437586	349186	5993882	0.8059	244737	197139	0.1614	5.343515	TCRB	47 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, Female, HLA-A*24, HLA-B*35, HLA-B*38, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP04498	517142	9630180	411049	7654527	0.7948	329177	263899	0.1807	4.740136	TCRB	42 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*24, HLA-B*14, HLA-B*41, Hispanic or Latino, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-B*14, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP12097	387622	8541105	309550	6820831	0.7986	263472	208290	0.1869	5.369434	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*29, HLA-A*68, HLA-B*14, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*29, Inferred HLA-B*14, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP09097	208076	7777824	173821	6497395	0.8354	149375	127326	0.0613	0.298427	TCRB	46 Years, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*03, HLA-B*15, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*03, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP12088	446366	7793772	359229	6272318	0.8048	366052	292305	0.0357	0.140666	TCRB	58 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*30, HLA-B*18, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*08, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01220	345646	8693424	274749	6910277	0.7949	227977	182268	0.1190	4.100299	TCRB	49 Years, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*32, HLA-B*44, HLA-B*60, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*32, Inferred HLA-B*44, Inferred HLA-B*60, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP02734	144314	4872627	116419	3930787	0.8067	107908	86706	0.0773	0.702378	TCRB	24 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*26, HLA-B*56, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-A*26, Inferred HLA-B*15, Inferred HLA-B*62, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP02947	615694	7360982	503621	6021088	0.8180	424493	346899	0.0910	1.236189	TCRB	39 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*24, HLA-B*38, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*38, Inferred HLA-B*51, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP09026	371870	9075082	308004	7516524	0.8283	252119	209949	0.1287	3.635417	TCRB	39 Years, Black or African American, Cohort 01, Cytomegalovirus +, HLA-A*03, HLA-A*68, HLA-B*41, HLA-B*58, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-B*14, Inferred HLA-B*58, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01798	404610	8863526	333803	7312413	0.8250	270501	218256	0.0984	3.091305	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*26, HLA-B*07, HLA-B*49, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*26, Inferred HLA-B*07, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP04634	427545	7635209	348658	6226440	0.8155	328088	265936	0.0603	0.300766	TCRB	10 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*24, HLA-B*08, HLA-B*38, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*08, Inferred HLA-B*38, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP04555	590093	8218753	465196	6479212	0.7883	438287	344384	0.0589	0.318773	TCRB	15 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*24, HLA-B*18, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*18, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP09159	172832	4797603	145494	4038751	0.8418	128991	106969	0.0629	0.868189	TCRB	36 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*24, HLA-A*32, HLA-B*44, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-B*15, Inferred HLA-B*44, Inferred HLA-B*62, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP12703	438612	9777930	382014	8516214	0.8710	239806	201349	0.2678	11.697675	TCRB	65 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*68, HLA-B*18, HLA-B*47, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*08, Inferred HLA-B*18, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01206	159953	5392405	134565	4536524	0.8413	116530	97106	0.0913	0.980552	TCRB	40 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*24, HLA-B*39, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-B*51, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01313	328414	7058410	265701	5710563	0.8090	249686	201783	0.0626	0.695378	TCRB	32 Years, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*24, HLA-B*07, HLA-B*08, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*07, Inferred HLA-B*08, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01795	321510	9998980	265471	8256192	0.8257	199761	162427	0.1425	2.421165	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*03, HLA-B*14, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*14, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP10376	181474	8011660	153566	6779624	0.8462	136988	114342	0.0646	1.077670	TCRB	35 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*23, HLA-B*35, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*23, Inferred HLA-A*29, Inferred HLA-B*35, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01391	285125	7754167	232785	6330753	0.8164	202563	163600	0.0749	0.408545	TCRB	43 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*33, HLA-B*14, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*14, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP10408	562898	8503670	460263	6953176	0.8177	352405	287285	0.1575	7.381994	TCRB	53 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*24, HLA-A*68, HLA-B*18, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Inferred HLA-A*68, Inferred HLA-B*18, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10480	443981	8094814	376425	6863112	0.8478	332848	279107	0.0947	1.182204	TCRB	11 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-B*50, HLA-B*55, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP03511	410061	5727253	340238	4752056	0.8297	251552	209027	0.1186	1.354340	TCRB	48 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*23, HLA-B*07, HLA-B*27, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*23, Inferred HLA-B*07, Inferred HLA-B*27, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10730	396837	8746670	328502	7240502	0.8278	193978	157673	0.1259	1.055327	TCRB	65 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*52, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10445	311153	7406121	260081	6190510	0.8359	227175	188038	0.0702	0.819496	TCRB	49 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*23, HLA-B*51, HLA-B*63, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*23, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10669	436201	9400872	352371	7594214	0.8078	298530	244989	0.1260	2.063176	TCRB	32 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*30, HLA-B*08, HLA-B*13, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13311	359098	7114971	313325	6208052	0.8725	225661	186957	0.2090	6.629809	TCRB	31 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*31, HLA-B*60, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*60, Inferred HLA-B*62, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03693	487491	6869465	395202	5568984	0.8107	371464	297186	0.0551	0.786786	TCRB	32 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*31, HLA-B*51, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP12143	347195	6202456	293309	5239823	0.8448	249931	212316	0.0681	1.227446	TCRB	42 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*11, HLA-A*25, HLA-B*18, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*11, Inferred HLA-A*25, Inferred HLA-B*18, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13228	421187	6783628	372344	5996969	0.8840	319543	281742	0.0580	0.803939	TCRB	Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*61, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13252	345250	9557886	270907	7499789	0.7847	258610	209457	0.0565	0.805303	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*03, HLA-B*35, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*35, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP03807	339894	9170102	283124	7638494	0.8330	221593	179748	0.1541	5.003382	TCRB	46 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*24, HLA-B*08, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*08, Inferred HLA-B*51, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13245	358067	9678282	293999	7946599	0.8211	209899	166469	0.1977	2.382038	TCRB	Cohort 01, Cytomegalovirus +, Human, Inferred CMV +, Inferred CMV +, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP05390	466185	8457297	361966	6566618	0.7764	345175	267445	0.0677	0.326942	TCRB	45 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*25, HLA-B*07, HLA-B*70, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01197	446135	8797561	366393	7225107	0.8213	313976	258726	0.0758	1.272106	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*26, HLA-B*08, HLA-B*38, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*26, Inferred HLA-B*08, Inferred HLA-B*38, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP11989	498008	10198619	412924	8456204	0.8292	332110	267070	0.1354	4.872056	TCRB	57 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*11, HLA-A*24, HLA-B*44, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*11, Inferred HLA-A*24, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP12980	416372	7774899	346198	6464561	0.8315	269490	226567	0.1141	1.475135	TCRB	45 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*24, HLA-B*08, HLA-B*18, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*08, Inferred HLA-B*18, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01465	296759	8141455	242790	6660851	0.8181	215348	172536	0.0846	1.208915	TCRB	Cohort 01, Cytomegalovirus +, Female, HLA-A*23, HLA-B*44, HLA-B*49, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*23, Inferred HLA-B*07, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP10568	375206	8831120	306111	7204856	0.8158	235998	189681	0.1494	7.086790	TCRB	49 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*03, HLA-B*13, HLA-B*60, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*08, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13303	376990	5489764	320644	4669260	0.8505	280706	235717	0.0755	4.171946	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*26, HLA-B*08, HLA-B*38, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*26, Inferred HLA-B*08, Inferred HLA-B*38, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP11937	450469	6665214	369185	5462532	0.8196	323788	264309	0.1000	1.768575	TCRB	55 Years, Black or African American, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*68, HLA-B*07, HLA-B*08, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*68, Inferred HLA-B*07, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05388	461988	7224805	386968	6051609	0.8376	283424	233425	0.1421	2.700604	TCRB	37 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*03, HLA-B*08, HLA-B*49, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP04597	370758	8772635	298771	7069326	0.8058	269270	214161	0.0641	0.360713	TCRB	42 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*29, HLA-B*07, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*29, Inferred HLA-B*07, Inferred HLA-B*60, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP02078	359085	8007663	313936	7000854	0.8743	232280	199582	0.1399	2.219515	TCRB	27 Years, Cohort 01, Cytomegalovirus +, HLA-A*11, HLA-A*30, HLA-B*35, HLA-B*39, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*11, Inferred HLA-A*30, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP04545	267899	4870662	219834	3996795	0.8206	208964	169648	0.0614	1.137637	TCRB	44 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*11, HLA-B*08, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*11, Inferred HLA-B*08, Inferred HLA-B*35, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01162	350653	8811045	289032	7262685	0.8243	252653	209869	0.0930	3.854332	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-B*07, HLA-B*08, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*08, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP09062	498518	5204552	404841	4226565	0.8121	367285	297756	0.0848	2.037021	TCRB	27 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*11, HLA-B*27, HLA-B*57, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*11, Inferred HLA-B*27, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP04605	444279	8310941	352784	6599383	0.7941	303116	243088	0.1097	1.278832	TCRB	56 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*26, HLA-B*08, HLA-B*22, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP11784	147631	7723946	124690	6523704	0.8446	122079	101425	0.0485	0.304612	TCRB	34 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*03, HLA-B*35, HLA-B*37, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-A*24, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01393	431909	9800959	354374	8041535	0.8205	320028	264666	0.0784	1.250856	TCRB	25 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*51, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13871	296699	10165985	233898	8014198	0.7883	212200	166914	0.0669	0.512253	TCRB	41 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*32, HLA-B*37, HLA-B*62, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*14, Inferred HLA-B*15, Inferred HLA-B*62, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13610	388460	6086337	307021	4810367	0.7904	232322	187013	0.1183	3.529980	TCRB	39 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*24, HLA-B*08, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*08, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13751	454512	9136362	366740	7372018	0.8069	296955	242799	0.0916	0.688550	TCRB	44 Years, Caucasian, Cohort 01, Cytomegalovirus +, Human, Inferred CMV +, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP09046	354398	6988268	285610	5631874	0.8059	273544	220672	0.0601	0.590762	TCRB	43 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*11, HLA-A*26, HLA-B*35, HLA-B*38, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*11, Inferred HLA-A*26, Inferred HLA-B*14, Inferred HLA-B*35, Inferred HLA-B*38, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13710	504753	7566146	409556	6139164	0.8114	348126	285036	0.0754	0.840375	TCRB	Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*26, HLA-B*50, HLA-B*52, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*26, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05942	476751	9914974	398303	8283508	0.8355	334490	276374	0.0942	1.263716	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*11, HLA-B*08, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-A*11, Inferred HLA-B*08, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP09789	613269	8694401	503393	7136682	0.8208	388638	314034	0.1628	5.045636	TCRB	32 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*11, HLA-B*13, HLA-B*37, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*11, Inferred HLA-B*37, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13865	174777	7060937	142973	5776069	0.8180	125326	102668	0.0754	0.952949	TCRB	43 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*24, HLA-B*35, HLA-B*44, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*35, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP13658	459321	5156732	364041	4087037	0.7926	381551	300753	0.0377	0.259944	TCRB	03 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*26, HLA-B*50, HLA-B*63, Human, Inferred CMV -, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08986	433738	6694084	330288	5097500	0.7615	254989	207055	0.1689	4.089848	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*15, Inferred HLA-B*62, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05563	268795	7161596	217674	5799585	0.8098	153438	126553	0.1266	1.507504	TCRB	66 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*31, HLA-B*60, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*60, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08890	320185	7825611	265679	6493447	0.8298	222991	185094	0.1009	1.724446	TCRB	Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*03, HLA-B*07, HLA-B*57, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP05559	500317	9311300	403385	7507328	0.8063	348154	283769	0.0789	1.892404	TCRB	21 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*03, HLA-B*05, HLA-B*07, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*03, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13518	290584	7799244	245681	6594077	0.8455	172766	140963	0.2376	9.852903	TCRB	55 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*11, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*11, Inferred HLA-B*07, Inferred HLA-B*44, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08702	388330	8264572	319328	6796050	0.8223	260718	215249	0.1182	3.107393	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-B*08, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*07, Inferred HLA-B*08, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP09051	343001	9176940	300762	8046862	0.8769	203165	170811	0.2120	17.402089	TCRB	51 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*33, HLA-B*07, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*51, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13636	705673	7862091	579209	6453125	0.8208	543824	447268	0.0740	1.011386	TCRB	46 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-B*35, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*26, Inferred HLA-B*35, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08989	525643	9247790	443993	7811306	0.8447	398666	334947	0.0622	0.911231	TCRB	50 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-A*26, HLA-B*07, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*26, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13893	563261	6746510	460538	5516139	0.8176	385998	317690	0.0679	0.746174	TCRB	33 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*23, HLA-A*32, HLA-B*44, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*23, Inferred HLA-B*44, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05960	434507	9665766	362323	8060020	0.8339	316055	259301	0.0979	2.997610	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*11, HLA-B*07, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*11, Inferred HLA-B*07, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP08076	505586	6800882	397940	5352891	0.7871	372382	290797	0.0531	0.855407	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*23, HLA-A*32, HLA-B*35, HLA-B*49, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-B*35, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13554	380832	7459940	319780	6264034	0.8397	238992	195218	0.1786	10.709760	TCRB	57 Years, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-B*08, HLA-B*57, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*08, Inferred HLA-B*57, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13363	390827	8833108	313583	7087316	0.8024	259319	206216	0.0841	0.832318	TCRB	32 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*32, HLA-B*08, HLA-B*18, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*08, Inferred HLA-B*18, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13987	360436	8484333	286841	6751980	0.7958	267769	211452	0.0879	1.135015	TCRB	24 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*32, HLA-B*35, HLA-B*39, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*32, Inferred HLA-B*35, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP19716	170516	4843382	133218	3783961	0.7813	127221	100720	0.0756	0.728945	TCRB	Cohort 01, HLA-A*01, HLA-B*08, Human, Inferred HLA-A*01, Inferred HLA-B*08, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13383	790690	3879454	657478	3225863	0.8315	256308	209852	0.1096	1.643870	TCRB	44 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-A*24, HLA-B*35, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-A*24, Inferred HLA-B*35, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14136	401076	5510824	342104	4700544	0.8530	248192	209296	0.1288	1.451662	TCRB	42 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*03, HLA-B*07, HLA-B*14, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*14, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP17462	403787	5197998	334773	4309576	0.8291	266080	225685	0.1139	3.309977	TCRB	47 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, HLA-A*11, HLA-A*24, HLA-B*07, HLA-B*08, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*11, Inferred HLA-A*24, Inferred HLA-B*07, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10814	472353	7244290	404327	6201008	0.8560	315414	267882	0.1291	3.032378	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*03, HLA-A*32, HLA-B*07, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*35, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13449	339462	8985100	280172	7415774	0.8253	188215	157016	0.1878	7.286333	TCRB	72 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*32, HLA-B*37, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*32, Inferred HLA-B*07, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14007	85096	4707972	67216	3718777	0.7899	73985	57625	0.0530	0.732499	TCRB	23 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13903	369281	5773965	284945	4455314	0.7716	211843	164535	0.1641	6.584093	TCRB	43 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*29, HLA-B*07, HLA-B*08, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14194	648075	8065245	536781	6680206	0.8283	499514	407531	0.0788	3.670740	TCRB	46 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*27, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-B*27, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP12534	402403	5858417	312008	4542403	0.7754	146640	119294	0.2530	8.425298	TCRB	50 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*25, HLA-B*44, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*25, Inferred HLA-B*44, Inferred HLA-B*51, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13945	115365	6548804	94663	5373663	0.8206	85837	68659	0.0679	0.609305	TCRB	51 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10507	352488	8290437	277825	6534390	0.7882	238904	190907	0.1036	1.373564	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus +, Human, Inferred CMV +, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP15861	251777	8027174	208678	6653112	0.8288	167244	135148	0.1104	4.494814	TCRB	55 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*25, HLA-A*29, HLA-B*44, HLA-B*58, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*29, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13473	529048	8801997	438950	7303005	0.8297	398714	327806	0.0548	0.190579	TCRB	47 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*70, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13986	313038	8401128	251432	6747809	0.8032	213388	168436	0.0954	1.150892	TCRB	53 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10716	554691	7938211	449505	6432889	0.8104	368738	295964	0.1107	0.982731	TCRB	61 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*15, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP19048	117861	6072474	93079	4795672	0.7897	67186	52200	0.0542	0.502203	TCRB	57 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*02, HLA-B*51, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP12538	397247	7870626	330202	6542287	0.8312	314643	259796	0.0574	0.345781	TCRB	24 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*24, HLA-A*26, HLA-B*35, HLA-B*38, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-A*26, Inferred HLA-B*35, Inferred HLA-B*38, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13291	490049	5482819	399543	4470218	0.8153	348635	282481	0.0565	0.611961	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-B*18, HLA-B*27, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*18, Inferred HLA-B*27, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10377	614104	9516811	496924	7700866	0.8092	453794	364256	0.0581	0.629786	TCRB	61 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*03, HLA-B*08, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*08, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP16738	418747	8143767	337270	6559224	0.8054	279374	220353	0.0768	0.502178	TCRB	Cohort 01, HLA-A*03, HLA-A*25, HLA-B*07, HLA-B*18, Human, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*18, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13396	550002	8860315	447469	7208561	0.8136	421237	337694	0.0859	3.427813	TCRB	56 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*02, HLA-B*57, HLA-B*73, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14202	205762	5595013	170277	4630121	0.8275	179340	147244	0.0515	0.959500	TCRB	22 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*07, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14240	400023	7561570	328077	6201591	0.8201	310208	253087	0.0584	1.158816	TCRB	23 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-B*08, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*08, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14000	662799	9202194	538709	7479358	0.8128	582851	469797	0.0394	1.094225	TCRB	24 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*68, HLA-B*51, HLA-B*55, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*68, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP17457	486185	8371786	402391	6928910	0.8276	337738	273763	0.1386	8.739340	TCRB	51 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*68, HLA-B*35, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*68, Inferred HLA-B*35, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP17577	422966	5638890	349235	4655929	0.8257	280770	229165	0.1234	6.765395	TCRB	51 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*11, HLA-B*08, HLA-B*39, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-A*11, Inferred HLA-B*08, Inferred HLA-B*39, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13949	250670	7925807	204974	6480982	0.8177	182800	144916	0.1216	1.580023	TCRB	47 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*11, HLA-B*50, HLA-B*52, Human, Inferred CMV +, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14039	307919	8397420	251814	6867354	0.8178	194983	157180	0.0898	1.318776	TCRB	32 Years, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*40, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*60, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14016	337974	5995076	274056	4861290	0.8109	253850	203395	0.0883	2.267526	TCRB	45 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*31, HLA-B*14, HLA-B*73, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*31, Inferred HLA-B*07, Inferred HLA-B*14, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP17657	341014	9475833	280936	7806447	0.8238	239177	194142	0.0735	1.147705	TCRB	Cohort 01, HLA-A*02, HLA-B*40, HLA-B*51, Human, Inferred HLA-A*02, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13988	262829	8132841	214942	6651068	0.8178	138835	116136	0.1805	5.194128	TCRB	61 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*29, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*29, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP15855	476961	8183742	372660	6394145	0.7813	340570	266954	0.0524	0.264977	TCRB	60 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*35, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*35, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP17698	383627	9178294	305745	7314985	0.7970	255775	206821	0.0978	3.066568	TCRB	43 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*03, HLA-B*08, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*08, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13324	442111	8725188	370450	7310956	0.8379	337727	280761	0.0571	0.706871	TCRB	55 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*11, HLA-B*07, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-B*08, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13771	676634	3143546	559650	2600056	0.8271	195498	159247	0.0927	1.801384	TCRB	52 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*24, HLA-B*35, HLA-B*38, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*35, Inferred HLA-B*38, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14227	515760	7747927	425262	6388448	0.8245	341036	276413	0.1110	2.955773	TCRB	45 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*23, HLA-B*07, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*23, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP17454	367614	7726951	304556	6401543	0.8285	290510	237233	0.0569	0.954036	TCRB	45 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, Human, Inferred CMV -, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14095	477773	10266114	405667	8716762	0.8491	353580	298088	0.0694	0.403200	TCRB	55 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*68, HLA-B*07, HLA-B*14, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*14, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP15685	312373	8255227	266183	7034546	0.8521	176053	141668	0.2931	14.937127	TCRB	55 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*24, HLA-A*32, HLA-B*38, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Inferred HLA-A*32, Inferred HLA-B*35, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14181	436739	7764184	369288	6565068	0.8456	325485	272257	0.0483	0.450947	TCRB	52 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-B*27, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*27, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP17845	345100	4239212	281733	3460820	0.8164	259959	215420	0.1046	2.229789	TCRB	34 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*03, HLA-B*08, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*51, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13780	616947	2900641	506114	2379552	0.8204	274942	223125	0.0304	0.108970	TCRB	43 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*29, HLA-B*44, HLA-B*45, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*29, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13592	776430	3489033	641544	2882902	0.8263	282114	230900	0.0685	0.411634	TCRB	52 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*29, HLA-A*31, HLA-B*27, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*29, Inferred HLA-A*31, Inferred HLA-B*27, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP12533	441194	8253170	361293	6758519	0.8189	313233	256143	0.0737	0.559842	TCRB	48 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*24, HLA-B*08, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*08, Inferred HLA-B*60, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13709	443253	9144684	365031	7530916	0.8235	307244	253071	0.0817	1.955659	TCRB	23 Years, Caucasian, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13352	513776	8687081	437331	7394539	0.8512	321222	272024	0.1115	1.570930	TCRB	43 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*24, HLA-A*32, HLA-B*35, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Inferred HLA-B*07, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08345	667329	3236833	566229	2746456	0.8485	291141	243897	0.0369	0.901926	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*26, HLA-B*08, HLA-B*38, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*26, Inferred HLA-B*08, Inferred HLA-B*38, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP16515	447925	9030478	356834	7194026	0.7966	231936	187059	0.2727	6.842594	TCRB	33 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*18, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*18, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13935	249647	5283243	215328	4556974	0.8625	196065	167936	0.0478	0.552604	TCRB	49 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*24, HLA-B*07, HLA-B*56, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*07, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP11058	442046	8882189	357438	7182142	0.8086	347662	282839	0.0558	0.503443	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*24, HLA-B*07, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*07, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP10389	360526	7889195	298333	6528267	0.8275	254473	207174	0.0586	0.807917	TCRB	50 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*37, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03630	725446	3157633	586797	2554140	0.8089	214220	175301	0.1178	3.907068	TCRB	46 Years, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*68, HLA-B*27, HLA-B*61, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*68, Inferred HLA-B*27, Male, Native American or Alaska Native, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP17534	493861	7602669	407180	6268284	0.8245	338037	279028	0.0868	0.848446	TCRB	55 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*15, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Inferred HLA-B*62, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13185	415711	7482268	328548	5913446	0.7903	283662	223185	0.0917	1.473033	TCRB	34 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-B*44, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*44, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10358	433154	5739939	368264	4880060	0.8502	297607	251080	0.0743	0.557268	TCRB	32 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*50, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-B*07, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13478	743426	3985209	610600	3273186	0.8213	168132	137215	0.2958	5.402473	TCRB	66 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*26, HLA-B*27, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*26, Inferred HLA-B*27, Inferred HLA-B*35, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP10447	397485	7796677	325768	6389961	0.8196	297275	243263	0.0900	1.402794	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*30, HLA-B*13, HLA-B*60, Hispanic or Latino, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*30, Inferred HLA-B*13, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP17760	368025	5981205	299701	4870807	0.8143	232236	187118	0.0856	0.503017	TCRB	56 Years, Black or African American, Cohort 01, Cytomegalovirus +, HLA-A*24, HLA-A*68, HLA-B*15, HLA-B*27, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*08, Inferred HLA-B*27, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP17585	484643	8311255	401865	6891683	0.8292	381093	316695	0.0665	0.530770	TCRB	58 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*24, HLA-A*29, HLA-B*44, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-A*29, Inferred HLA-B*44, Inferred HLA-B*57, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14911	340023	7022014	284009	5865252	0.8353	244493	202287	0.0729	0.300908	TCRB	42 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*11, HLA-A*32, HLA-B*07, HLA-B*15, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-B*07, Inferred HLA-B*62, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP17440	437920	7793918	349775	6225153	0.7987	358634	291584	0.0414	0.399058	TCRB	06 Years, Caucasian, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14107	118579	6294665	100425	5330996	0.8469	90689	75684	0.1011	1.698895	TCRB	40 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*30, HLA-A*68, HLA-B*13, HLA-B*48, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*30, Inferred HLA-A*68, Inferred HLA-B*13, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP14217	421931	10129125	325533	7814956	0.7715	299354	229991	0.0673	0.376906	TCRB	41 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*24, HLA-B*40, HLA-B*41, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14494	542320	8762674	429708	6943124	0.7924	460895	360686	0.0244	0.043064	TCRB	02 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*03, HLA-B*56, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP19717	500362	8890566	404198	7181900	0.8078	341001	281474	0.1071	3.883972	TCRB	48 Years, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-B*18, HLA-B*35, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*08, Inferred HLA-B*18, Inferred HLA-B*35, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP14124	512612	7873375	419010	6435723	0.8174	365844	295092	0.0734	1.382160	TCRB	37 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-B*07, HLA-B*50, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13932	738158	3442329	636180	2966766	0.8618	233502	200595	0.1116	3.192433	TCRB	42 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*31, HLA-B*15, HLA-B*27, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*27, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13996	789854	4260183	669835	3612848	0.8480	266591	222735	0.1202	2.249084	TCRB	44 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*26, HLA-B*08, HLA-B*39, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*07, Inferred HLA-B*08, Inferred HLA-B*39, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14041	1157632	4699082	980849	3981482	0.8473	399639	330964	0.1560	3.605341	TCRB	52 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*24, HLA-B*07, HLA-B*55, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*07, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14089	584308	2972750	480825	2446269	0.8229	232844	192302	0.0664	1.768326	TCRB	36 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*23, HLA-B*49, HLA-B*58, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13793	900787	3963454	779938	3431722	0.8658	213910	177042	0.3270	12.495884	TCRB	46 Years, Caucasian, Cohort 01, Cytomegalovirus +, Human, Inferred CMV +, Inferred CMV +, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14226	510672	3187920	423722	2645129	0.8297	191586	156108	0.0620	0.593695	TCRB	51 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*24, HLA-A*25, HLA-B*18, HLA-B*50, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*24, Inferred HLA-A*25, Inferred HLA-B*07, Inferred HLA-B*18, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14022	975618	4458287	787512	3598699	0.8072	383395	304676	0.0482	0.701309	TCRB	36 Years, Black or African American, Cohort 01, Cytomegalovirus +, Female, HLA-A*33, HLA-A*68, HLA-B*78, HLA-B*82, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*68, Inferred HLA-B*08, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13355	636041	10219107	520378	8360786	0.8182	393602	315552	0.1675	5.305793	TCRB	39 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*03, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*62, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13376	na	5622097	na	4613417	0.8206	411273	338495	0.0386	0.155936	TCRB	14 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*29, HLA-B*14, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*29, Inferred HLA-B*14, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13854	na	668837	na	552176	0.8256	61501	50339	0.0363	0.256078	TCRB	34 Years, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP01181	na	3611036	na	2822615	0.7817	102017	82209	0.1670	3.262329	TCRB	Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*26, HLA-B*08, HLA-B*61, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13309	na	6542352	na	5402870	0.8258	429849	358356	0.0548	0.377114	TCRB	33 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*25, HLA-A*33, HLA-B*08, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-B*08, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13981	na	4447720	na	3636741	0.8177	213139	174484	0.0797	1.412198	TCRB	44 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*15, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*62, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14064	na	3452500	na	2940552	0.8517	310173	265370	0.0437	0.677458	TCRB	61 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-B*08, HLA-B*15, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*08, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13939	na	3975962	na	3220377	0.8100	267205	217049	0.0677	0.362908	TCRB	44 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*68, HLA-B*14, HLA-B*15, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*07, Inferred HLA-B*14, Inferred HLA-B*62, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13749	na	5974207	na	4888107	0.8182	289975	233834	0.0647	0.429328	TCRB	22 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*31, HLA-B*15, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*31, Inferred HLA-B*35, Inferred HLA-B*62, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13869	na	1773136	na	1478000	0.8336	161169	134658	0.0706	1.509811	TCRB	25 Years, Cohort 01, Cytomegalovirus +, HLA-A*01, HLA-A*68, HLA-B*08, HLA-B*44, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*68, Inferred HLA-B*08, Inferred HLA-B*44, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14213	na	3643224	na	2944539	0.8082	260624	212125	0.0681	2.738663	TCRB	60 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*31, HLA-B*15, HLA-B*18, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-B*18, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14209	na	3726851	na	2956225	0.7932	174386	136005	0.0776	3.303876	TCRB	60 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*11, HLA-A*26, HLA-B*38, HLA-B*40, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*26, Inferred HLA-B*38, Inferred HLA-B*60, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13511	na	3671509	na	3011676	0.8203	292766	240681	0.0622	0.859355	TCRB	46 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*68, HLA-B*18, HLA-B*52, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*68, Inferred HLA-B*18, Inferred HLA-B*35, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13951	na	5710169	na	4714587	0.8256	409325	335179	0.0456	0.674842	TCRB	05 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-A*68, HLA-B*07, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05757	na	1550189	na	1291348	0.8330	111659	90906	0.0729	0.589307	TCRB	42 Years, Cohort 01, Cytomegalovirus -, Female, HLA-A*01, HLA-A*34, HLA-B*08, HLA-B*14, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-B*08, Inferred HLA-B*14, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13350	na	4532628	na	3732289	0.8234	245731	202584	0.0916	0.790025	TCRB	36 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*23, HLA-A*29, HLA-B*07, HLA-B*38, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*29, Inferred HLA-B*38, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13806	na	2809493	na	2267311	0.8070	157436	127546	0.1100	1.758735	TCRB	45 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*02, HLA-B*08, HLA-B*27, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13318	na	1927017	na	1543383	0.8009	159412	132397	0.1330	2.612378	TCRB	Cohort 01, Cytomegalovirus +, Female, HLA-A*03, HLA-B*14, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*13, Inferred HLA-B*14, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14152	na	4230058	na	3371394	0.7970	82020	65628	0.3038	10.048840	TCRB	48 Years, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*68, HLA-B*39, HLA-B*52, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP13769	na	4559108	na	3897797	0.8549	236598	200416	0.0689	1.074145	TCRB	26 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*03, HLA-B*07, HLA-B*57, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*57, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13958	na	5409678	na	4595814	0.8496	306691	258179	0.0640	0.701290	TCRB	36 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*24, HLA-A*31, HLA-B*08, HLA-B*40, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13831	na	4692490	na	3824058	0.8149	149119	122004	0.1019	0.806395	TCRB	41 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*03, HLA-B*08, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*08, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13992	na	4894367	na	3996747	0.8166	105882	85881	0.2254	3.247591	TCRB	20 Years, Cohort 01, Cytomegalovirus +, HLA-A*11, HLA-A*36, HLA-B*35, HLA-B*37, Hispanic or Latino, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*11, Inferred HLA-B*35, Inferred HLA-B*37, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown racial group, gDNA
HIP05941	na	3455494	na	2812234	0.8138	267329	220633	0.0517	0.553261	TCRB	25 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*51, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13975	na	4350007	na	3522227	0.8097	363702	296160	0.0455	0.247997	TCRB	24 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*03, HLA-B*08, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*08, Inferred HLA-B*35, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP14121	na	3732263	na	3001275	0.8041	258248	207286	0.0730	0.967889	TCRB	49 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*11, HLA-A*31, HLA-B*35, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*11, Inferred HLA-B*35, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13741	na	6703374	na	5673505	0.8464	378826	315990	0.1014	4.858619	TCRB	39 Years, Caucasian, Cohort 01, Cytomegalovirus -, Human, Inferred CMV -, Inferred CMV -, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08339	na	2042182	na	1735211	0.8497	242389	206227	0.0365	0.220953	TCRB	19 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*03, HLA-B*07, HLA-B*08, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*07, Inferred HLA-B*08, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13967	na	3735818	na	3137014	0.8397	220861	185475	0.1415	1.546630	TCRB	47 Years, Asian or Pacific Islander, Cohort 01, Cytomegalovirus +, HLA-A*02, HLA-A*03, HLA-B*07, HLA-B*40, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-B*07, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13244	na	5046131	na	4175696	0.8275	234627	192940	0.0770	1.017723	TCRB	39 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*01, HLA-A*24, HLA-B*08, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*08, Inferred HLA-B*44, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13803	na	4301047	na	3523725	0.8193	277626	228674	0.0631	0.524303	TCRB	49 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*02, HLA-A*31, HLA-B*51, HLA-B*56, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*31, Inferred HLA-B*51, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13916	na	4336000	na	3554247	0.8197	142941	113500	0.0985	0.868735	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*30, HLA-B*13, HLA-B*15, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13823	na	4285758	na	3563096	0.8314	190464	159729	0.0880	0.949062	TCRB	38 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, Human, Inferred CMV -, Inferred CMV -, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13875	na	1936771	na	1660398	0.8573	114154	92813	0.2600	13.983394	TCRB	49 Years, Caucasian, Cohort 01, Cytomegalovirus +, HLA-A*03, HLA-B*35, HLA-B*60, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*02, Inferred HLA-A*03, Inferred HLA-B*35, Inferred HLA-B*60, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP13847	na	1100187	na	961637	0.8741	79496	68872	0.0645	1.238201	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*68, HLA-B*13, HLA-B*51, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*30, Inferred HLA-A*68, Inferred HLA-B*13, Inferred HLA-B*44, Inferred HLA-B*51, Inferred HLA-B*57, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13515	na	2621825	na	2310307	0.8812	160243	134846	0.2901	16.022806	TCRB	58 Years, Cohort 01, Cytomegalovirus +, HLA-A*30, HLA-A*33, HLA-B*07, HLA-B*35, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-B*35, Inferred HLA-B*37, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP00614	na	1937837	na	1585816	0.8183	128274	105597	0.0944	1.085183	TCRB	27 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*03, HLA-A*29, HLA-B*07, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-B*07, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP08596	na	1378575	na	1030323	0.7474	115853	95837	0.1633	4.509557	TCRB	61 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*01, HLA-A*03, HLA-B*08, HLA-B*18, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*03, Inferred HLA-B*08, Inferred HLA-B*18, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP11711	na	2681420	na	2242197	0.8362	135723	113136	0.1103	2.510306	TCRB	35 Years, Cohort 01, Cytomegalovirus +, HLA-A*24, HLA-B*51, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*24, Inferred HLA-B*51, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP19089	na	846399	na	739989	0.8743	76837	66657	0.0932	1.953002	TCRB	Cohort 01, HLA-A*01, HLA-A*80, HLA-B*13, HLA-B*44, Human, Inferred HLA-A*01, Inferred HLA-A*29, Inferred HLA-B*44, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13402	na	913096	na	760946	0.8334	67911	56599	0.0841	2.116182	TCRB	Cohort 01, Cytomegalovirus -, Female, HLA-A*03, HLA-A*30, HLA-B*07, HLA-B*13, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*03, Inferred HLA-A*30, Inferred HLA-B*07, Inferred HLA-B*13, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP14844	na	1088882	na	919777	0.8447	112515	94948	0.0623	2.619983	TCRB	Cohort 01, HLA-A*01, HLA-A*24, HLA-B*44, HLA-B*57, Human, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-B*44, Inferred HLA-B*57, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP10424	na	1193611	na	1022032	0.8563	82691	69681	0.0798	2.873491	TCRB	37 Years, Cohort 01, Cytomegalovirus +, Female, HLA-A*02, HLA-A*24, HLA-B*07, HLA-B*62, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*01, Inferred HLA-A*02, Inferred HLA-A*24, Inferred HLA-B*08, Inferred HLA-B*15, Inferred HLA-B*51, Inferred HLA-B*62, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP03385	na	1757835	na	1520338	0.8649	166088	141917	0.0278	0.144113	TCRB	55 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-A*03, HLA-B*27, HLA-B*60, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP01765	na	909674	na	753346	0.8281	72720	59552	0.0568	0.331986	TCRB	48 Years, Cohort 01, Cytomegalovirus +, Female, Human, Inferred CMV +, Inferred CMV +, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP13760	na	1607983	na	1346349	0.8373	95622	79690	0.1223	1.796785	TCRB	Cohort 01, Cytomegalovirus -, HLA-A*11, HLA-A*24, HLA-B*44, HLA-B*55, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*11, Inferred HLA-A*24, Inferred HLA-A*29, Inferred HLA-B*13, Inferred HLA-B*44, Inferred HLA-B*55, Male, PBMC, Peripheral blood lymphocytes (PBL), T cells, Unknown Ethnicity, Unknown racial group, gDNA
HIP08821	na	1718164	na	1404224	0.8173	113510	94927	0.1327	3.740785	TCRB	55 Years, Caucasian, Cohort 01, Cytomegalovirus +, Female, HLA-A*29, HLA-A*30, HLA-B*13, HLA-B*57, Human, Inferred CMV +, Inferred CMV +, Inferred HLA-A*29, Inferred HLA-A*30, Inferred HLA-B*13, Inferred HLA-B*44, Inferred HLA-B*57, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP05552	na	2465129	na	2048661	0.8311	307882	254868	0.0367	0.318550	TCRB	53 Years, Caucasian, Cohort 01, Cytomegalovirus -, Female, HLA-A*24, HLA-A*68, HLA-B*08, HLA-B*44, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*01, Inferred HLA-A*24, Inferred HLA-A*68, Inferred HLA-B*08, Inferred HLA-B*44, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
HIP03484	na	2279679	na	1924907	0.8444	151582	127105	0.0877	1.081039	TCRB	46 Years, Caucasian, Cohort 01, Cytomegalovirus -, HLA-A*02, HLA-B*07, HLA-B*58, Human, Inferred CMV -, Inferred CMV -, Inferred HLA-A*02, Inferred HLA-A*26, Inferred HLA-B*38, Male, Non-Hispanic or Latino, PBMC, Peripheral blood lymphocytes (PBL), T cells, gDNA
